WO2013051831A2 - Composition for forming an alignment layer, and alignment layer and phase difference film manufactured using same - Google Patents

Composition for forming an alignment layer, and alignment layer and phase difference film manufactured using same Download PDF

Info

Publication number
WO2013051831A2
WO2013051831A2 PCT/KR2012/007964 KR2012007964W WO2013051831A2 WO 2013051831 A2 WO2013051831 A2 WO 2013051831A2 KR 2012007964 W KR2012007964 W KR 2012007964W WO 2013051831 A2 WO2013051831 A2 WO 2013051831A2
Authority
WO
WIPO (PCT)
Prior art keywords
group
carbon atoms
substituted
methyl
unsubstituted
Prior art date
Application number
PCT/KR2012/007964
Other languages
French (fr)
Korean (ko)
Other versions
WO2013051831A3 (en
Inventor
송병훈
조민성
최봉진
Original Assignee
동우화인켐 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020110102640A external-priority patent/KR20130038020A/en
Application filed by 동우화인켐 주식회사 filed Critical 동우화인켐 주식회사
Priority to CN201280049523.4A priority Critical patent/CN103857751A/en
Publication of WO2013051831A2 publication Critical patent/WO2013051831A2/en
Publication of WO2013051831A3 publication Critical patent/WO2013051831A3/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/29Compounds containing one or more carbon-to-nitrogen double bonds

Definitions

  • the present invention relates to a composition for forming an alignment film, and an alignment film prepared therefrom and a retardation film having excellent interlayer adhesion.
  • three-dimensional image display technology uses a binocular parallax, which is the biggest factor for recognizing three-dimensional effect at a close range.
  • the principle of binocular parallax is a method of photographing a left eye image viewed through a left eye and a right eye image viewed through a right eye from at least two stereoscopic image capturing cameras, and then separating and transmitting them to the viewer's eyes. This is possible because two human eyes receive objects through the retina from different angles and these two images are synthesized in the cerebrum.
  • the way of wearing glasses is (1) anaglyph method that uses sunglasses of colors that are distinct from each other, (2) polarization method that uses polarized glasses with different polarization directions, and (3) time-divided screen There is a time-sharing method of wearing glasses with an electronic shutter that is periodically repeated and synchronized with the period.
  • the polarized glasses are able to express a three-dimensional feeling regardless of the viewer's position, and have the most attention because they have less dizziness or fatigue of eyes and are easy to manufacture.
  • a display device for displaying a stereoscopic image using polarized glasses includes a patterned retardation film (having a patterned retardation layer formed on the substrate), and the patterned retardation film is formed by applying an adhesive or an adhesive to one side of the polarizing plate. Is bonded.
  • This patterned retardation film has a structure in which a transparent substrate, an alignment film and a cured liquid crystal layer are sequentially stacked.
  • the retardation film has a problem that the adhesion strength between the layers is small, the interlayer peeling of the retardation film occurs in the process of removing the protective film after attaching the retardation film on the substrate with an adhesive.
  • An object of the present invention is to provide a composition for forming an alignment film which can improve the adhesive force with another film in contact with the alignment film.
  • an object of this invention is to provide the retardation film excellent in the adhesive force between layers in the retardation film provided with an oriented film.
  • An alignment film-forming composition for forming an alignment film for orienting a liquid crystal compound comprising: an alignment film including an adhesion enhancing agent including an isocyanate group and a (meth) acrylate group at its terminals that may be bonded to a reactive group of the liquid crystal compound. Formation composition.
  • composition of claim 1 wherein the reactive group of the liquid crystal compound is a carbon-carbon unsaturated bond, a hydroxyl group, an epoxy group, or a cyano group.
  • adhesion enhancer is at least one selected from the group consisting of compounds of Formulas 1 to 4 below:
  • R 1 and R 2 are each independently hydrogen or a methyl group
  • R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
  • R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
  • R 7 and R 8 are each independently hydrogen or a methyl group
  • R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 10 is (a) Or (b) E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
  • R 12 is hydrogen or a methyl group
  • R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group;
  • R 14 is hydrogen or a methyl group
  • R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  • composition of claim 3, wherein the adhesion enhancer is a mixture of any one of the compounds represented by Formulas 2 to 4 and the compound represented by Formula 1.
  • the composition for forming an alignment film comprising a polymer containing a cinnamate group as a photo-alignment agent.
  • composition for forming an alignment film including 0.1 to 20 parts by weight of the adhesion enhancer with respect to 100 parts by weight of the optical alignment agent.
  • a retardation film comprising a substrate, an alignment film of 9 above formed on the substrate, and a liquid crystal layer formed on the alignment film.
  • the substrate is a retardation film comprising a reactive group that can be bonded to the isocyanate group and (meth) acrylate groups contained in the adhesion enhancer of the composition for forming the alignment film on its surface.
  • the alignment layer is a phase difference film bonded by the substrate and the urethane bond, thiene bond or carbon-carbon saturated bond.
  • the substrate is a retardation film containing triacetyl cellulose-based, cycloolefin-based or PMMA-based polymer.
  • the retardation film of claim 14, wherein the surface treatment is at least one treatment selected from the group consisting of saponification treatment, primer treatment, corona treatment, plasma treatment, and coating treatment.
  • the retardation film of claim 15, wherein the plasma treatment is at least one selected from the group consisting of a remote plasma treatment, a direct plasma treatment, and a monomer plasma treatment.
  • urethane bond is formed by the reaction of an isocyanate group of the compound represented by any one of formulas 1 to 4 of the alignment layer with the hydroxyl group, thiol group, carboxyl group, amine group or epoxy group of the substrate Retardation film:
  • R 1 and R 2 are each independently hydrogen or a methyl group
  • R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
  • R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
  • R 7 and R 8 are each independently hydrogen or a methyl group
  • R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 10 is (a) Or (b) E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
  • R 12 is hydrogen or a methyl group
  • R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group;
  • R 14 is hydrogen or a methyl group
  • R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  • R 1 and R 2 are each independently hydrogen or a methyl group
  • R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
  • R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
  • R 7 and R 8 are each independently hydrogen or a methyl group
  • R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 10 is (a) Or (b) E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
  • R 12 is hydrogen or a methyl group
  • R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group;
  • R 14 is hydrogen or a methyl group
  • R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  • R 1 and R 2 are each independently hydrogen or a methyl group
  • R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
  • R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
  • R 7 and R 8 are each independently hydrogen or a methyl group
  • R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 10 is (a) Or (b) E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
  • R 12 is hydrogen or a methyl group
  • R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group;
  • R 14 is hydrogen or a methyl group
  • R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  • liquid crystal layer is formed of a liquid crystal compound having a carbon-carbon unsaturated bond, a hydroxyl group, an epoxy group, or a cyano group.
  • R 1 and R 2 are each independently hydrogen or a methyl group
  • R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
  • R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
  • R 7 and R 8 are each independently hydrogen or a methyl group
  • R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 10 is (a) Or (b) E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
  • R 12 is hydrogen or a methyl group
  • R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group;
  • R 14 is hydrogen or a methyl group
  • R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  • R 1 and R 2 are each independently hydrogen or a methyl group
  • R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
  • R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
  • R 7 and R 8 are each independently hydrogen or a methyl group
  • R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 10 is (a) Or (b) E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
  • R 12 is hydrogen or a methyl group
  • R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group;
  • R 14 is hydrogen or a methyl group
  • R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  • R 1 and R 2 are each independently hydrogen or a methyl group
  • R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
  • R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
  • R 7 and R 8 are each independently hydrogen or a methyl group
  • R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 10 is (a) or (b)
  • E 1 and E 3 are each independently an alkyl group having 1 to 10 carbon atoms substituted or unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms, or an alkoxy group having 1 to 8 carbon atoms
  • E 2 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms
  • R 12 is hydrogen or a methyl group
  • R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group;
  • R 14 is hydrogen or a methyl group
  • R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  • liquid crystal layer retardation film containing 0.1 to 15 parts by weight of the adhesion strength enhancer based on 100 parts by weight of the liquid crystal compound.
  • composition for forming an alignment film of the present invention may be used to prepare a retardation film having a very high adhesion between the layers by chemically forming bonds with different layers formed on both sides in the process of curing the alignment film.
  • the retardation film of the present invention has a very high interlayer adhesion, the peeling phenomenon is remarkably reduced in manufacturing an optical film such as a polarizing film using the retardation film, thereby lowering a defective rate and thus improving productivity.
  • 1 is a schematic cross-sectional view of a retardation film.
  • the present invention provides a composition for forming an alignment film for forming an alignment film for orienting a liquid crystal compound, the composition comprising an adhesion enhancing agent comprising an isocyanate group and a (meth) acrylate group at its terminals that can be bonded to a reactive group of the liquid crystal compound.
  • the present invention relates to a composition for forming an alignment film used in the production of a retardation film having a very high interlayer adhesion by chemically forming a bond with another layer formed on the side surface in the process of curing the alignment film.
  • the composition for forming an alignment film of the present invention is characterized by including an adhesion enhancing agent capable of chemically bonding with another layer formed on the side of the alignment film.
  • the adhesion enhancer according to the present invention comprises at least one (meth) acrylate group terminal and one isocyanate group terminal.
  • (meth) acrylate means acrylate or methacrylate.
  • the (meth) acrylate group and the isocyanate group of the adhesion enhancer are liquid crystalline compounds even if the (meth) acrylate group and / or the isocyanate group are not contained at the terminal at the time when the adhesion enhancer is mixed with the composition for forming an alignment film.
  • functional groups where (meth) acrylate groups or isocyanate groups are produced through further treatment, such as heat treatment, prior to chemical bonding with the substrate.
  • a functional group in which an isocyanate group is produced through heat treatment a pyrazole group connected by an amide bond to the terminal of the adhesion promoter may be mentioned. Gastric pyrazole groups are separated through a heat treatment process, an isocyanate group is formed at the end.
  • an alignment film is a layer which induces alignment of liquid crystals
  • an alignment film used for a retardation film or the like is in contact with the liquid crystal layer on one surface thereof and in contact with the base film on the other side thereof.
  • the interlayer adhesion may be enhanced by chemically bonding the reactive groups exposed on the surface of the liquid crystal layer to which the above isocyanate group and the (meth) acrylate group contact each other, and more preferably the reactive groups on the surface of the base film.
  • Examples of the reactive group of the liquid crystal compound forming the liquid crystal layer in contact with one surface of the alignment film include carbon-carbon unsaturated bonds, hydroxyl groups, epoxy groups, cyano groups, and the like, and preferably carbon-carbon unsaturated bonds. More specifically, the carbon-carbon unsaturated bond may be a carbon-carbon unsaturated bond included in an acryloyloxy group, cyanoacrylate group, allyl group, cinnamate group, or allyloxy group.
  • any base material having a reactive group among the liquid crystal compounds used in the art may be used in the present invention without limitation, and the liquid crystal compounds commonly used in the art may be known in the art even if they do not have such a reactive group.
  • Any reactive group can be introduced at the end through the pretreatment process and can be used in the present invention without limitation.
  • the substrate in contact with the other surface of the alignment film may also have a reactive group capable of reacting with an isocyanate group or a (meth) acrylate group on its surface.
  • a reactive group capable of reacting with an isocyanate group or a (meth) acrylate group on its surface.
  • a reactive group a hydroxyl group, a thiol group, a carboxy group, a (meth) acrylate group, an amine group, an epoxy group, etc. are mentioned.
  • any substrate having such a reactive group among the substrates used in the art can be used in the present invention without limitation, and a substrate treatment process known in the art even if the substrate commonly used in the art does not have such a reactive group per se. If the reactive group can be introduced to the surface through may be used in the present invention without limitation.
  • adhesion enhancer may be one or more selected from the group consisting of compounds represented by the following formula (1), (2), (3) and (4):
  • R 1 and R 2 are each independently hydrogen or a methyl group
  • R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
  • R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
  • R 7 and R 8 are each independently hydrogen or a methyl group
  • R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 10 is (a) Or (b) E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
  • R 12 is hydrogen or a methyl group
  • R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group;
  • R 14 is hydrogen or a methyl group
  • R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  • the adhesion enhancer represented by Chemical Formula 1 to Chemical Formula 4 is at least one of the compounds represented by Chemical Formula 2 to Chemical Formula 4 and the compound represented by Chemical Formula 1 to secure better interlayer adhesion. It can be used as a mixture of.
  • adhesion enhancer of Formula 1 to Formula 4 may include at least one selected from the group consisting of compounds represented by the following Formulas 5 to 15:
  • composition for forming an alignment layer of the present invention may include a photo-alignment agent, a photoinitiator and an organic solvent commonly used in the art in addition to the above adhesion enhancer.
  • a photoalignment agent a photoalignment agent conventionally used in the art may be used without particular limitation.
  • a polymer having a cinnamate group and having a weight average molecular weight of about 10,000-500,000 may be used, but is not limited thereto.
  • Adhesion enhancers according to the present invention is preferably included in 0.1 to 20 parts by weight relative to 100 parts by weight of the photo-alignment agent. It is possible to secure sufficient adhesive strength in the above range, when excessively added, the adhesive strength is improved, but when applied to the optical film, other physical properties may be lowered.
  • photoinitiators conventionally used in the art may be used without particular limitation.
  • a triazine compound an acetophenone compound, a biimidazole compound, an oxime compound, a benzoin compound, a benzophenone compound, a thioxanthone compound, an anthracene compound, etc. may be used, but is not limited thereto. no.
  • triazine-based compound for example, 2,4-bis (trichloromethyl) -6- (4-methoxyphenyl) -1,3,5-triazine, 2,4-bis (trichloromethyl)- 6- (4-methoxynaphthyl) -1,3,5-triazine, 2,4-bis (trichloromethyl) -6-piperonyl-1,3,5-triazine, 2,4- Bis (trichloromethyl) -6- (4-methoxystyryl) -1,3,5-triazine, 2,4-bis (trichloromethyl) -6- [2- (5-methylfuran-2 -Yl) ethenyl] -1,3,5-triazine, 2,4-bis (trichloromethyl) -6- [2- (furan-2-yl) ethenyl] -1,3,5-tri Azine, 2,4-bis (trichloromethyl) -6- [2- (4-dieth
  • acetophenone-based compound for example, diethoxyacetophenone, 2-hydroxy-2-methyl-1-phenylpropan-1-one, benzyl dimethyl ketal, 2-hydroxy-1- [4- (2 -Hydroxyethoxy) phenyl] -2-methylpropane-1-one, 1-hydroxycyclohexylphenyl ketone, 2-methyl-1- (4-methylthiophenyl) -2-morpholinopropane-1- On, 2-benzyl-2-dimethylamino-1- (4-morpholinophenyl) butan-1-one, 2-hydroxy-2-methyl-1- [4- (1-methylvinyl) phenyl] propane Oligomer of -1-one, 2-methyl-2-amino (4-morpholinophenyl) ethan-1-one, 2-ethyl-2-amino (4-morpholinophenyl) ethan-1-one, 2 -Propyl-2-amino (4-morpholinophenyl)
  • biimidazole-based compound for example, 2,2'-bis (2-chlorophenyl) -4,4 ', 5,5'-tetraphenylbiimidazole, 2,2'-bis (2,3 -Dichlorophenyl) -4,4 ', 5,5'-tetraphenylbiimidazole, 2,2'-bis (2-chlorophenyl) -4,4', 5,5'-tetra (alkoxyphenyl) ratio Imidazole, 2,2'-bis (2-chlorophenyl) -4,4 ', 5,5'-tetra (trialkoxyphenyl) biimidazole, phenyl group at 4,4', 5,5 'position And imidazole compounds substituted with a boalkoxy group.
  • 2,2'bis (2-chlorophenyl) -4,4 ', 5,5'-tetra phenylbiimidazole, 2,2'-bis (2,3-dichlorophenyl) -4,4', 5,5'-tetraphenylbiimidazole is preferably used.
  • Examples of the above oxime compounds include 0-ethoxycarbonyl- ⁇ -oxyimino-1-phenylpropan-1-one and the like.
  • benzoin type compound benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, benzoin isobutyl ether, etc. are mentioned, for example.
  • benzophenone-based compound for example, benzophenone, methyl 0-benzoylbenzoate, 4-phenylbenzophenone, 4-benzoyl-4'-methyldiphenyl sulfide, 3,3 ', 4,4'-tetra ( tert-butylperoxycarbonyl) benzophenone, 2,4,6-trimethylbenzophenone, etc. are mentioned.
  • thioxanthone-based compound examples include 2-isopropyl thioxanthone, 2,4-diethyl thioxanthone, 2,4-dichloro thioxanthone, 1-chloro-4-propoxy thioxanthone, and the like. Can be mentioned.
  • anthracene-based compound examples include 9,10-dimethoxyanthracene, 2-ethyl-9,10-dimethoxyanthracene, 9,10-diethoxyanthracene, 2-ethyl-9,10-diethoxyanthracene, and the like. Can be mentioned.
  • the composition for forming an alignment film of the present invention may not include a photoinitiator.
  • Photoinitiators have the advantage of facilitating the photopolymerization reaction of the photo-alignment agent. However, when the photoinitiator is used in an excessive amount, it acts as an impurity, lowers the orientation force, breaks down the liquid crystal orientation, and may cause light leakage phenomenon during cross polarization, or the photoinitiator may be sublimated after photocuring to contaminate the mask. When the intensity of the initiator reaction wavelength is very high compared to the wavelength at which the reaction occurs, side effects may be reduced such as lowering the line speed for the optical alignment. In this aspect, the composition for forming an alignment film of the present invention may or may not contain a very small amount of photoinitiator.
  • an organic solvent conventionally used in the art may be used without particular limitation.
  • Ethylene glycol monoalkyl ethers such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether and ethylene glycol monobutyl ether;
  • Diethylene glycol dialkyl ethers such as diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol ethyl methyl ether, diethylene glycol dipropyl ether and diethylene glycol dibutyl ether;
  • Ethylene glycol alkyl ether acetates such as methyl cellosolve acetate, ethyl cellosolve acetate, ethylene glycol monobutyl ether acetate, and ethylene glycol monoethyl ether acetate;
  • Alkylene glycol alkyl ether acetates such as propylene glycol monomethyl ether acetate, propylene glycol
  • composition for forming an alignment film of the present invention may further include additives such as fillers, curing agents, leveling agents, adhesion promoters, antioxidants, ultraviolet absorbers, anti-aggregation agents, chain transfer agents and the like, as necessary.
  • composition for forming an alignment film of the present invention forms an alignment film through a curing process, and may be applied without limitation as long as a conventionally used alignment film is used.
  • it can be usefully used for the patterned retardation film (patterned retarder) provided in the display apparatus used for three-dimensional image display.
  • the structure of a conventional retardation film is shown in FIG.
  • the retardation film 100 has a structure in which an alignment layer 130 is interposed between the transparent substrate 110 and the photocurable liquid crystal layer 120.
  • the transparent substrate 110 according to the present invention is preferably reactive to react with isocyanate groups or (meth) acrylate groups, such as hydroxyl groups, thiol groups, carboxyl groups, (meth) acrylate groups, amine groups or epoxy groups on the surface. It may have a group.
  • the transparent substrate 110 according to the present invention may be used without limitation as long as it is a substrate having such a reactive group among substrates commonly used in the art, and even without such a reactive group, the reactive group is introduced to the surface through a pretreatment process known in the art. If possible, it can be used in the present invention without limitation.
  • a transparent film is generally used.
  • a film including a triacetyl cellulose (TAC), a cyclo-olefin polymer (COP), a poly (methyl methacrylate) polymer, or the like is used.
  • TAC triacetyl cellulose
  • COP cyclo-olefin polymer
  • a poly (methyl methacrylate) polymer or the like.
  • Substrates made of TAC, COP, PMMA do not have reactive groups on their surface that can react with isocyanates or (meth) acrylates. Therefore, the reactive group can be introduced to the surface through surface treatment.
  • the hydroxyl group is described as an example, the hydroxyl group is introduced to the surface when the saponification treatment is performed on the TAC surface, and the hydroxyl group is applied to the surface when the plasma treatment is performed on the surface of the COP. Can be introduced.
  • cellulose-based film is alkali treatment including saponification treatment; Acrylic, polyolefin and polyester films are advantageous for dry treatment such as corona treatment or plasma treatment.
  • plasma treatment at least one process may be performed among a remote plasma, a direct plasma, and a monomer plasma.
  • the photocurable liquid crystal layer 120 is prepared by curing a composition comprising a liquid crystal compound having a carbon-carbon unsaturated carbon bond, a hydroxyl group, an epoxy group or a cyano group, a polymerization initiator, and an organic solvent at the end thereof,
  • a photopolymerization initiator or a thermal polymerization initiator may be used, and the photoinitiator exemplified above may be used as the photopolymerization initiator.
  • An organic solvent may also be appropriately selected from among the organic solvents exemplified above.
  • the composition for forming the photocurable liquid crystal layer 20 may further include an adhesion enhancer according to the present invention described above.
  • an adhesion enhancer according to the present invention described above.
  • a carbon-carbon saturated bond is formed between the isocyanate group and the (meth) acrylate group containing both of the liquid crystal layer and the alignment layer at the end thereof, so that the adhesion between the layers can be further improved. desirable.
  • the content of the adhesion enhancing agent while containing 0.1 to 15 parts by weight of the adhesion enhancing agent with respect to 100 parts by weight of the liquid crystal compound effectively exerts the effect of strengthening the adhesion between the substrate and the alignment film and between the alignment film and the liquid crystal layer, the liquid crystal orientation It is preferable in terms of maintaining and not lowering the phase difference.
  • the reactive groups exposed on the surfaces of the transparent substrate 110 and the photocurable liquid crystal layer 120 may be the same or different.
  • the alignment layer 130 is an isocyanate group capable of forming a chemical bond by reacting with a reactive group on the surface of the transparent substrate 110 and a reactive group of the liquid crystal compound exposed on the surface of the photocurable liquid crystal layer 120 and a (meth) ) Adhesion enhancer comprising an acrylate group at the end.
  • the isocyanate end of the adhesion promoter may react with the hydroxyl group, thiol group, carboxyl group, amine group, epoxy group or cyano group of the transparent substrate 110 or the photocurable liquid crystal layer 120 to form a urethane bond.
  • the isocyanate end of the adhesion promoter may react with the hydroxyl group, thiol group, carboxyl group, amine group, epoxy group or cyano group of the transparent substrate 110 or the photocurable liquid crystal layer 120 to form a urethane bond.
  • the hydroxyl, thiol, carboxyl, amine, epoxy or cyano group reacts with the isocyanate group to form a urethane bond as follows.
  • the cyano group may be pretreated with H 2 O while being heated, transformed into an amine group or carboxylic acid, and reacted with an isocyanate group.
  • the (meth) acrylate end of the adhesion enhancing agent of the alignment layer reacts with the (meth) acrylate group and the carbon-carbon unsaturated bond of the transparent substrate 110 or the photocurable liquid crystal layer 120 It may form a carbon-carbon saturated bond.
  • the liquid crystal layer 120 includes an adhesion enhancer
  • each (meth) acrylate terminal of the adhesion enhancer of the alignment layer and the adhesion enhancer of the liquid crystal layer may react to form a carbon-carbon saturated bond.
  • the (meth) acrylate end of the adhesion enhancer may react with the thiol group of the transparent substrate 110 to form a thiylene bond.
  • the alignment layer 130 of the present invention is attached to the transparent substrate 110 and the photocurable liquid crystal layer 120 with high adhesion.
  • the retardation film according to the present invention is applied to the alignment layer composition according to the invention on a transparent substrate and then dried and exposed to form a pattern on the alignment layer, and then the photocurable liquid crystal layer forming composition on the alignment layer and dried photocurable It can be prepared by carrying out the process.
  • the chemical bonding of the alignment film and the liquid crystal layer according to the present invention is made in the curing process of the liquid crystal layer, and the chemical bonding of the alignment film and the transparent substrate is made in a drying process (heat treatment).
  • a composition for forming an alignment layer was prepared by mixing a photo-alignment agent, an adhesion enhancing agent, a photoinitiator (Irgacure 907, manufactured by BASF) and an organic solvent (toluene) in the composition shown in Table 1 below (unit: g).
  • compositions of Examples 1-7 and Comparative Examples 1-2 prepared were saponified and applied to Fuji TAC Film having a hydroxyl group introduced thereon, dried at 100 ° C. for 1 minute, and then subjected to exposure to produce alignment films. It was. Applying a photocurable liquid crystal composition (RMS) comprising a liquid crystal compound having a carbon-carbon unsaturated bond on the terminal on the upper alignment layer and dried at a temperature of 60 °C for 1 minute, and then exposed to induce a curing reaction to give a retardation film Prepared.
  • RMS photocurable liquid crystal composition
  • a liquid crystal compound (RMS), an adhesion enhancing agent, a photoinitiator (Irgacure 907, manufactured by BASF), and an organic solvent (toluene) were mixed in the composition shown in Table 2 to prepare a composition for forming a liquid crystal layer (unit: g).
  • a photo-alignment agent an adhesion enhancing agent, a photoinitiator (Irgacure 907, manufactured by BASF) and an organic solvent (toluene) were mixed with the composition shown in Table 2 to prepare an alignment film-forming composition (unit: g).
  • Example 8-14 and Comparative Example 3-4 Apply the alignment film forming composition of Example 8-14 and Comparative Example 3-4 to Fuji TAC film having a hydroxyl group introduced to the surface by saponification, and dried at 100 ° C. for 1 minute, followed by exposure to each alignment film. Produced.
  • the composition for forming a liquid crystal layer of Example 8-14 and Comparative Example 3-4 was coated on the alignment layer and dried at a temperature of 60 ° C. for 1 minute, and then exposed to induce a curing reaction to prepare a retardation film.
  • the retardation film of the embodiments according to the present invention exhibits the same or similar optical performance as the retardation film of the comparative examples, it can be seen that the interlayer adhesion is superior to the comparative examples.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Polarising Elements (AREA)

Abstract

The present invention relates to a composition for forming an alignment layer and to an alignment layer manufactured using same. More particularly, the present invention relates to a composition for forming an alignment layer for aligning liquid crystal compounds. The composition includes an adhesion-reinforcing agent including an isocyanate group and a (meth)acrylate group at an end portion for forming a bond with a reactive group in the liquid crystal compound. While curing the composition for forming the alignment layer, a chemical bond may be formed with another layer formed at the side portion so as to manufacture a phase difference film having very strong interlayer adhesion.

Description

배향막 형성용 조성물, 그로부터 제조된 배향막 및 위상차 필름Composition for forming an alignment film, alignment film and retardation film prepared therefrom
본 발명은 배향막 형성용 조성물 및 그로부터 제조된 배향막과 이를 구비하여 층간 접착력이 우수한 위상차 필름에 관한 것이다.The present invention relates to a composition for forming an alignment film, and an alignment film prepared therefrom and a retardation film having excellent interlayer adhesion.
사람이 입체감을 느끼는 요인은 생리적인 요인과 경험적인 요인이 있다. 일반적으로 3차원 화상표시 기술은 근거리에서 입체감을 인식하는 가장 큰 요인인 양안시차(binocular parallax)를 이용하고 있다.The factors that make a person feel three-dimensional are physiological and empirical factors. In general, three-dimensional image display technology uses a binocular parallax, which is the biggest factor for recognizing three-dimensional effect at a close range.
양안시차 원리는 적어도 두 개의 입체 화상 취득용 카메라로 서로 다른 각도에서 시청자가 좌안을 통하여 시청하는 좌안상과 우안을 통하여 시청하는 우안상을 촬영한 후 이를 분리하여 시청자의 눈에 전달하는 방식이다. 인간의 두 눈이 각기 다른 각도에서 망막을 통하여 사물을 받아들이고 이들 두 개의 상이 대뇌에서 합성됨으로써 가능한 것이다.The principle of binocular parallax is a method of photographing a left eye image viewed through a left eye and a right eye image viewed through a right eye from at least two stereoscopic image capturing cameras, and then separating and transmitting them to the viewer's eyes. This is possible because two human eyes receive objects through the retina from different angles and these two images are synthesized in the cerebrum.
입체 화상을 관측하는 방식은 크게 안경을 착용하는 방식과 안경을 착용하지 않는 무안경 방식이 있다. 안경을 착용하는 방식은 (1) 양안에 각각 서로 구분되는 색상들의 색안경을 쓰는 애너그리프(anaglyph)방식, (2) 각각 편광 방향이 다른 편광안경을 쓰는 편광방식, 및 (3) 시간 분할된 화면을 주기적으로 반복시키고 이 주기에 동기시킨 전자 셔터가 설치된 안경을 쓰는 시분할방식 등이 있다.There are two methods of observing a stereoscopic image, a method of wearing glasses and a glasses-free method of not wearing glasses. The way of wearing glasses is (1) anaglyph method that uses sunglasses of colors that are distinct from each other, (2) polarization method that uses polarized glasses with different polarization directions, and (3) time-divided screen There is a time-sharing method of wearing glasses with an electronic shutter that is periodically repeated and synchronized with the period.
이 중에서 편광방식을 채택한 안경은 시청자의 위치에 상관없이 입체감을 표현할 수 있으며 어지러움증이나 눈의 피로감이 적고 제조도 용이하여 가장 주목을 받고 있다.Among them, the polarized glasses are able to express a three-dimensional feeling regardless of the viewer's position, and have the most attention because they have less dizziness or fatigue of eyes and are easy to manufacture.
편광방식 안경을 이용하는 입체 화상을 표시하는 디스플레이 장치에는 패턴화된 위상차 필름(기재에 패턴화된 위상차층이 형성된 것)이 포함되며, 패턴화된 위상차 필름은 편광판의 한 면에 접착제 또는 점착제를 매개로 접합된다.A display device for displaying a stereoscopic image using polarized glasses includes a patterned retardation film (having a patterned retardation layer formed on the substrate), and the patterned retardation film is formed by applying an adhesive or an adhesive to one side of the polarizing plate. Is bonded.
이러한 패턴화된 위상차 필름은 투명 기재, 배향막 및 경화 액정층이 순차로 적층된 구조를 갖는다. 그런데, 위 위상차 필름은 각 층간의 접착강도가 작아서, 위상차 필름을 점착제로 기판 상에 부착한 후 보호필름을 제거하는 공정에서 위상차 필름의 층간 박리가 발생하는 문제점이 있다.This patterned retardation film has a structure in which a transparent substrate, an alignment film and a cured liquid crystal layer are sequentially stacked. However, the retardation film has a problem that the adhesion strength between the layers is small, the interlayer peeling of the retardation film occurs in the process of removing the protective film after attaching the retardation film on the substrate with an adhesive.
본 발명은 배향막과 접촉하는 다른 막과의 접착력을 향상시킬 수 있는 배향막 형성용 조성물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a composition for forming an alignment film which can improve the adhesive force with another film in contact with the alignment film.
또한, 본 발명은 배향막을 구비하는 위상차 필름에 있어서, 층간의 접착력이 우수한 위상차 필름을 제공하는 것을 목적으로 한다.Moreover, an object of this invention is to provide the retardation film excellent in the adhesive force between layers in the retardation film provided with an oriented film.
1. 액정성 화합물을 배향시키기 위한 배향막을 형성하는 배향막 형성용 조성물로서, 상기 액정성 화합물의 반응성기와 결합될 수 있는 이소시아네이트기 및 (메타)아크릴레이트기를 그 말단에 포함하는 접착력 강화제를 포함하는 배향막 형성용 조성물.1. An alignment film-forming composition for forming an alignment film for orienting a liquid crystal compound, comprising: an alignment film including an adhesion enhancing agent including an isocyanate group and a (meth) acrylate group at its terminals that may be bonded to a reactive group of the liquid crystal compound. Formation composition.
2. 위 1에 있어서, 상기 액정성 화합물의 반응성기는 탄소-탄소 불포화 결합, 수산기, 에폭시기 또는 시아노기인 배향막 형성용 조성물.2. The composition of claim 1, wherein the reactive group of the liquid crystal compound is a carbon-carbon unsaturated bond, a hydroxyl group, an epoxy group, or a cyano group.
3. 위 1에 있어서, 상기 접착력 강화제는 하기 화학식 1 내지 4의 화합물로 이루어진 군에서 선택된 1 종 이상의 것인 배향막 형성용 조성물:3. The composition of claim 1, wherein the adhesion enhancer is at least one selected from the group consisting of compounds of Formulas 1 to 4 below:
[화학식 1][Formula 1]
Figure PCTKR2012007964-appb-I000001
Figure PCTKR2012007964-appb-I000001
(식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
[화학식 2][Formula 2]
Figure PCTKR2012007964-appb-I000002
Figure PCTKR2012007964-appb-I000002
(식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R10는 (a)
Figure PCTKR2012007964-appb-I000003
또는 (b)
Figure PCTKR2012007964-appb-I000004
이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),
R 10 is (a)
Figure PCTKR2012007964-appb-I000003
Or (b)
Figure PCTKR2012007964-appb-I000004
E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
[화학식 3][Formula 3]
Figure PCTKR2012007964-appb-I000005
Figure PCTKR2012007964-appb-I000005
(식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
[화학식 4][Formula 4]
Figure PCTKR2012007964-appb-I000006
Figure PCTKR2012007964-appb-I000006
(식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
4. 위 3에 있어서, 상기 접착력 강화제는 상기 화학식 2 내지 화학식 4로 표시되는 화합물 중 어느 하나와 상기 화학식 1로 표시되는 화합물의 혼합물인 배향막 형성용 조성물.4. The composition of claim 3, wherein the adhesion enhancer is a mixture of any one of the compounds represented by Formulas 2 to 4 and the compound represented by Formula 1.
5. 위 1에 있어서, 신나메이트기를 포함하는 고분자를 광배향제로 포함하는 배향막 형성용 조성물.5. according to the above 1, the composition for forming an alignment film comprising a polymer containing a cinnamate group as a photo-alignment agent.
6. 위 5에 있어서, 상기 광배향제 100 중량부에 대하여 0.1 중량부 내지 20 중량부의 접착력 강화제를 포함하는 배향막 형성용 조성물.6. In the above 5, the composition for forming an alignment film, including 0.1 to 20 parts by weight of the adhesion enhancer with respect to 100 parts by weight of the optical alignment agent.
7. 위 1에 있어서, 트리아진계 화합물, 아세토페논계 화합물, 비이미다졸계 화합물, 옥심계 화합물, 벤조인계 화합물, 벤조페논계 화합물, 티오크산톤계 화합물 및 안트라센계 화합물로 이루어진 군에서 선택되는 1종 이상의 광개시제를 포함하는 배향막 형성용 조성물.7. In the above 1, selected from the group consisting of triazine compound, acetophenone compound, biimidazole compound, oxime compound, benzoin compound, benzophenone compound, thioxanthone compound and anthracene compound Composition for forming an alignment film comprising at least one photoinitiator.
8. 위 1에 있어서, 에틸렌글리콜모노메틸에테르, 에틸렌글리콜모노에틸에테르, 에틸렌글리콜모노프로필에테르, 에틸렌글리콜모노부틸에테르, 디에틸렌글리콜디메틸에테르, 디에틸렌글리콜디에틸에테르, 디에틸렌글리콜에틸메틸에테르, 디에틸렌글리콜디프로필에테르, 디에틸렌글리콜디부틸에테르, 메틸셀로솔브아세테이트, 에틸셀로솔브아세테이트, 에틸렌글리콜모노부틸에테르아세테이트, 에틸렌글리콜모노에틸에테르아세테이트, 프로필렌글리콜모노메틸에테르아세테이트, 프로필렌글리콜모노에틸에테르아세테이트, 프로필렌글리콜모노프로필에테르아세테이트, 메톡시부틸아세테이트, 메톡시펜틸아세테이트, 프로필렌글리콜모노메틸에테르, 프로필렌글리콜모노에틸에테르, 프로필렌글리콜모노프로필에테르, 프로필렌글리콜모노부틸에테르, 프로필렌글리콜디메틸에테르, 프로필렌글리콜디에틸에테르, 프로필렌글리콜에틸메틸에테르, 프로필렌글리콜디프로필에테르프로필렌글리콜프로필메틸에테르, 프로필렌글리콜에틸프로필에테르, 프로필렌글리콜메틸에테르프로피오네이트, 프로필렌글리콜에틸에테르프로피오네이트, 프로필렌글리콜프로필에테르프로피오네이트, 프로필렌글리콜부틸에테르프로피오네이트, 메톡시부틸알코올, 에톡시부틸알코올, 프로폭시부틸알코올, 부톡시부틸알코올, 메톡시부틸아세테이트, 에톡시부틸아세테이트, 프로폭시부틸아세테이트, 부톡시부틸아세테이트, 메톡시부틸프로피오네이트, 에톡시부틸프로피오네이트, 프로폭시부틸프로피오네이트, 부톡시부틸프로피오네이트, 디프로필렌글리콜디메틸에테르, 디프로필렌글리콜디에틸에테르, 디프로필렌글리콜메틸에틸에테르, 벤젠, 톨루엔, 자일렌, 메시틸렌, 메틸에틸케톤, 아세톤, 메틸아밀케톤, 메틸이소부틸케톤, 시클로헥사논, 에탄올, 프로판올, 부탄올, 헥산올, 시클로헥산올, 에틸렌글리콜, 글리세린, 아세트산메틸, 아세트산에틸, 아세트산프로필, 아세트산부틸, 2-히드록시프로피온산에틸, 2-히드록시-2-메틸프로피온산메틸, 2-히드록시-2-메틸프로피온산에틸, 히드록시아세트산메틸, 히드록시아세트산에틸, 히드록시아세트산부틸, 락트산메틸, 락트산에틸, 락트산프로필, 락트산부틸, 3-히드록시프로피온산메틸, 3-히드록시프로피온산에틸, 3-히드록시프로피온산프로필, 3-히드록시프로피온산부틸, 2-히드록시-3-메틸부탄산메틸, 메톡시아세트산메틸, 메톡시아세트산에틸, 메톡시아세트산프로필, 메톡시아세트산부틸, 에톡시아세트산메틸, 에톡시아세트산에틸, 에톡시아세트산프로필, 에톡시아세트산부틸, 프로폭시아세트산메틸, 프로폭시아세트산에틸, 프로폭시아세트산프로필, 프로폭시아세트산부틸, 부톡시아세트산메틸, 부톡시아세트산에틸, 부톡시아세트산프로필, 부톡시아세트산부틸, 2-메톡시프로피온산메틸, 2-메톡시프로피온산에틸, 2-메톡시프로피온산프로필, 2-메톡시프로피온산부틸, 2-에톡시프로피온산메틸, 2-에톡시프로피온산에틸, 2-에톡시프로피온산프로필, 2-에톡시프로피온산부틸, 2-부톡시프로피온산메틸, 2-부톡시프로피온산에틸, 2-부톡시프로피온산프로필, 2-부톡시프로피온산부틸, 3-메톡시프로피온산메틸, 3-메톡시프로피온산에틸, 3-메톡시프로피온산프로필, 3-메톡시프로피온산부틸, 3-에톡시프로피온산메틸, 3-에톡시프로피온산에틸, 3-에톡시프로피온산프로필, 3-에톡시프로피온산부틸, 3-프로폭시프로피온산메틸, 3-프로폭시프로피온산에틸, 3-프로폭시프로피온산프로필, 3-프로폭시프로피온산부틸, 3-부톡시프로피온산메틸, 3-부톡시프로피온산에틸, 3-부톡시프로피온산프로필, 3-부톡시프로피온산부틸, 테트라히드로푸란, 피란 및 γ-부티로락톤으로 이루어진 군에서 선택되는 1종 이상의 유기용매를 포함하는 배향막 형성용 조성물.8. In the above 1, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, ethylene glycol monobutyl ether, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol ethyl methyl ether , Diethylene glycol dipropyl ether, diethylene glycol dibutyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, ethylene glycol monobutyl ether acetate, ethylene glycol monoethyl ether acetate, propylene glycol monomethyl ether acetate, propylene glycol Monoethyl ether acetate, propylene glycol monopropyl ether acetate, methoxy butyl acetate, methoxypentyl acetate, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monopropyl ether, propylene glycol monobutyl ether Le, propylene glycol dimethyl ether, propylene glycol diethyl ether, propylene glycol ethyl methyl ether, propylene glycol dipropyl ether propylene glycol propyl methyl ether, propylene glycol ethyl propyl ether, propylene glycol methyl ether propionate, propylene glycol ethyl ether propio Nitrate, propylene glycol propyl ether propionate, propylene glycol butyl ether propionate, methoxybutyl alcohol, ethoxybutyl alcohol, propoxybutyl alcohol, butoxybutyl alcohol, methoxybutyl acetate, ethoxybutyl acetate, propoxy Butyl acetate, butoxybutyl acetate, methoxybutyl propionate, ethoxybutyl propionate, propoxybutyl propionate, butoxybutyl propionate, dipropylene glycol dimethyl ether, dipropylene glycol diethyl ether, di profile Ethylene glycol methyl ethyl ether, benzene, toluene, xylene, mesitylene, methyl ethyl ketone, acetone, methyl amyl ketone, methyl isobutyl ketone, cyclohexanone, ethanol, propanol, butanol, hexanol, cyclohexanol, ethylene glycol , Glycerin, methyl acetate, ethyl acetate, propyl acetate, butyl acetate, ethyl 2-hydroxypropionate, methyl 2-hydroxy-2-methylpropionate, ethyl 2-hydroxy-2-methylpropionate, methyl hydroxyacetate, hydroxide Ethyl hydroxy acetate, butyl hydroxy acetate, methyl lactate, ethyl lactate, propyl lactate, butyl lactate, methyl 3-hydroxypropionate, ethyl 3-hydroxypropionate, 3-hydroxypropionate, butyl 3-hydroxypropionate, 2 -Hydroxy-3-methylbutyrate, methyl methoxyacetate, ethyl methoxyacetate, methoxyacetic propyl, methoxy butyl acetate, methyl ethoxyacetate, Ethyl acetate, propyl ethoxyacetate, butyl ethoxyacetate, methyl propoxyacetate, ethyl propoxyacetate, propyl propoxyacetate, butyl propoxyacetate, methyl butoxyacetate, ethyl butoxyacetate, butoxypropyl propyl, Butoxy Butyl Acetate, 2-Methoxy Propionate, 2-Methyl Propionate, 2-Methyl Propionate, 2-Methoxy Propionate, 2-Methoxypropionate, 2-Ethoxy Propionate, 2-E Propyl oxypropionate, butyl 2-ethoxypropionate, methyl 2-butoxypropionate, ethyl 2-butoxypropionate, propyl 2-butoxypropionate, butyl 2-butoxypropionate, methyl 3-methoxypropionate, 3-methoxy Ethyl propionate, propyl 3-methoxypropionate, butyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, propyl 3-ethoxypropionate, 3- Butyl oxypropionate, 3-propoxy methyl propionate, 3-propoxy propionate, 3-propoxy propionate, 3-butyl propoxypropionate, 3-butoxy methyl propionate, 3-butoxy ethyl propionate, 3-butoxy A composition for forming an alignment film comprising at least one organic solvent selected from the group consisting of propyl propionate, butyl 3-butoxypropionate, tetrahydrofuran, pyran and γ-butyrolactone.
9. 위 1 내지 8 중 어느 한 항의 배향막 형성용 조성물로 형성된 배향막.9. The alignment film formed of the composition for forming an alignment film of any one of the above 1 to 8.
10. 기재, 상기 기재 상에 형성된 위 9의 배향막, 및 상기 배향막 상에 형성된 액정층을 포함하는 위상차 필름.10. A retardation film comprising a substrate, an alignment film of 9 above formed on the substrate, and a liquid crystal layer formed on the alignment film.
11. 위 10에 있어서, 상기 기재는 그 표면에 상기 배향막 형성용 조성물의 접착력 강화제에 포함된 이소시아네이트기 및 (메타)아크릴레이트기와 결합될 수 있는 반응성기를 포함하는 위상차 필름.11. In the above 10, wherein the substrate is a retardation film comprising a reactive group that can be bonded to the isocyanate group and (meth) acrylate groups contained in the adhesion enhancer of the composition for forming the alignment film on its surface.
12. 위 11에 있어서, 상기 기재 표면의 반응성기는 수산기, 티올기, 카르복시기, (메타)아크릴레이트기, 아민기 또는 에폭시기인 위상차 필름.12. The retardation film of 11 above, wherein the reactive group on the surface of the substrate is a hydroxyl group, a thiol group, a carboxyl group, a (meth) acrylate group, an amine group, or an epoxy group.
13. 위 11에 있어서, 상기 배향막은 상기 기재와 우레탄 결합, 티올렌 결합 또는 탄소-탄소 포화결합에 의해 접합된 위상차 필름.13. In the above 11, wherein the alignment layer is a phase difference film bonded by the substrate and the urethane bond, thiene bond or carbon-carbon saturated bond.
14. 위 11에 있어서, 상기 기재는 표면처리된 트리아세틸셀룰로오스계, 사이클로올레핀계 또는 PMMA계 중합체를 포함하는 위상차 필름.14. In the above 11, wherein the substrate is a retardation film containing triacetyl cellulose-based, cycloolefin-based or PMMA-based polymer.
15. 위 14에 있어서, 상기 표면처리는 검화 처리, 프라이머 처리, 코로나 처리, 플라즈마 처리 및 코팅 처리로 이루어진 군에서 선택되는 적어도 하나의 처리인 위상차 필름.15. The retardation film of claim 14, wherein the surface treatment is at least one treatment selected from the group consisting of saponification treatment, primer treatment, corona treatment, plasma treatment, and coating treatment.
16. 위 15에 있어서, 상기 플라즈마 처리는 원격 플라즈마(Remote plasma) 처리, 직접 플라즈마(Direct plasma) 처리 및 단량체 플라즈마(Monomer plasma) 처리로 이루어진 군에서 선택되는 적어도 하나인 위상차 필름.16. The retardation film of claim 15, wherein the plasma treatment is at least one selected from the group consisting of a remote plasma treatment, a direct plasma treatment, and a monomer plasma treatment.
17. 위 13에 있어서, 상기 우레탄 결합은 상기 배향막의 하기 화학식 1 내지 4 중 어느 하나로 표시되는 화합물의 이소시아네이트기와 상기 기재의 수산기, 티올기, 카르복시기, 아민기 또는 에폭시기의 반응에 의해 형성되는 것인 위상차 필름:17. In the above 13, wherein the urethane bond is formed by the reaction of an isocyanate group of the compound represented by any one of formulas 1 to 4 of the alignment layer with the hydroxyl group, thiol group, carboxyl group, amine group or epoxy group of the substrate Retardation film:
[화학식 1][Formula 1]
Figure PCTKR2012007964-appb-I000007
Figure PCTKR2012007964-appb-I000007
(식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
[화학식 2][Formula 2]
Figure PCTKR2012007964-appb-I000008
Figure PCTKR2012007964-appb-I000008
(식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R10는 (a)
Figure PCTKR2012007964-appb-I000009
또는 (b)
Figure PCTKR2012007964-appb-I000010
이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),
R 10 is (a)
Figure PCTKR2012007964-appb-I000009
Or (b)
Figure PCTKR2012007964-appb-I000010
E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
[화학식 3][Formula 3]
Figure PCTKR2012007964-appb-I000011
Figure PCTKR2012007964-appb-I000011
(식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
[화학식 4][Formula 4]
Figure PCTKR2012007964-appb-I000012
Figure PCTKR2012007964-appb-I000012
(식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
18. 위 13에 있어서, 상기 탄소-탄소 포화 결합은 상기 배향막의 하기 화학식 1 내지 4 중 어느 하나로 표시되는 화합물의 (메타)아크릴레이트기와 상기 기재의 (메타)아크릴레이트기의 반응에 의해 형성되는 것인 위상차 필름:18. In the above 13, wherein the carbon-carbon saturated bond is formed by the reaction of the (meth) acrylate of the compound represented by any one of the following formulas 1 to 4 of the alignment layer and the (meth) acrylate group of the substrate Retardation film being:
[화학식 1][Formula 1]
Figure PCTKR2012007964-appb-I000013
Figure PCTKR2012007964-appb-I000013
(식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
[화학식 2][Formula 2]
Figure PCTKR2012007964-appb-I000014
Figure PCTKR2012007964-appb-I000014
(식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R10는 (a)
Figure PCTKR2012007964-appb-I000015
또는 (b)
Figure PCTKR2012007964-appb-I000016
이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),
R 10 is (a)
Figure PCTKR2012007964-appb-I000015
Or (b)
Figure PCTKR2012007964-appb-I000016
E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
[화학식 3][Formula 3]
Figure PCTKR2012007964-appb-I000017
Figure PCTKR2012007964-appb-I000017
(식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
[화학식 4][Formula 4]
Figure PCTKR2012007964-appb-I000018
Figure PCTKR2012007964-appb-I000018
(식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
19. 위 13에 있어서, 상기 티올렌 결합은 상기 배향막의 하기 화학식 1 내지 4 중 어느 하나로 표시되는 화합물의 (메타)아크릴레이트기와 상기 기재의 티올기의 반응에 의해 형성되는 것인 위상차 필름:19. The retardation film of claim 13, wherein the thiylene bond is formed by a reaction of a (meth) acrylate group of a compound represented by any one of the following Chemical Formulas 1 to 4 of the alignment layer with a thiol group of the substrate:
[화학식 1][Formula 1]
Figure PCTKR2012007964-appb-I000019
Figure PCTKR2012007964-appb-I000019
(식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
[화학식 2][Formula 2]
Figure PCTKR2012007964-appb-I000020
Figure PCTKR2012007964-appb-I000020
(식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R10는 (a)
Figure PCTKR2012007964-appb-I000021
또는 (b)
Figure PCTKR2012007964-appb-I000022
이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),
R 10 is (a)
Figure PCTKR2012007964-appb-I000021
Or (b)
Figure PCTKR2012007964-appb-I000022
E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
[화학식 3][Formula 3]
Figure PCTKR2012007964-appb-I000023
Figure PCTKR2012007964-appb-I000023
(식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
[화학식 4][Formula 4]
Figure PCTKR2012007964-appb-I000024
Figure PCTKR2012007964-appb-I000024
(식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
20. 위 10에 있어서, 상기 배향막은 상기 액정층과 우레탄 결합 또는 탄소-탄소 포화 결합으로 접합된 위상차 필름.20. The retardation film of 10 above, wherein the alignment layer is bonded to the liquid crystal layer and a urethane bond or a carbon-carbon saturated bond.
21. 위 10에 있어서, 상기 액정층은 탄소-탄소 불포화 결합, 수산기, 에폭시기 또는 시아노기를 갖는 액정성 화합물로 형성된 것인 위상차 필름.21. The retardation film of claim 10, wherein the liquid crystal layer is formed of a liquid crystal compound having a carbon-carbon unsaturated bond, a hydroxyl group, an epoxy group, or a cyano group.
22. 위 20에 있어서, 상기 우레탄 결합은 상기 배향막의 하기 화학식 1 내지 4 중 어느 하나로 표시되는 화합물의 이소시아네이트기와 상기 액정층의 액정성 화합물의 수산기, 에폭시기 또는 시아노기의 반응에 의해 형성되는 것인 위상차 필름:22. In the above 20, wherein the urethane bond is formed by the reaction of an isocyanate group of the compound represented by any one of the following formula 1 to 4 of the alignment layer and the hydroxyl group, epoxy group or cyano group of the liquid crystal compound of the liquid crystal layer Retardation film:
[화학식 1][Formula 1]
Figure PCTKR2012007964-appb-I000025
Figure PCTKR2012007964-appb-I000025
(식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
[화학식 2][Formula 2]
Figure PCTKR2012007964-appb-I000026
Figure PCTKR2012007964-appb-I000026
(식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R10는 (a)
Figure PCTKR2012007964-appb-I000027
또는 (b)
Figure PCTKR2012007964-appb-I000028
이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),
R 10 is (a)
Figure PCTKR2012007964-appb-I000027
Or (b)
Figure PCTKR2012007964-appb-I000028
E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
[화학식 3][Formula 3]
Figure PCTKR2012007964-appb-I000029
Figure PCTKR2012007964-appb-I000029
(식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
[화학식 4][Formula 4]
Figure PCTKR2012007964-appb-I000030
Figure PCTKR2012007964-appb-I000030
(식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
23. 위 20에 있어서, 상기 탄소-탄소 포화 결합은 상기 배향막의 하기 화학식 1 내지 4 중 어느 하나로 표시되는 화합물의 (메타)아크릴레이트기와 상기 액정층의 액정성 화합물의 탄소-탄소 불포화 결합의 반응에 의해 형성되는 것인 위상차 필름:23. The reaction of 20 above, wherein the carbon-carbon saturated bond is a reaction of a (meth) acrylate group of a compound represented by one of the following Chemical Formulas 1 to 4 of the alignment layer with a carbon-carbon unsaturated bond of the liquid crystal compound of the liquid crystal layer: Retardation film formed by:
[화학식 1][Formula 1]
Figure PCTKR2012007964-appb-I000031
Figure PCTKR2012007964-appb-I000031
(식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
[화학식 2][Formula 2]
Figure PCTKR2012007964-appb-I000032
Figure PCTKR2012007964-appb-I000032
(식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R10는 (a)
Figure PCTKR2012007964-appb-I000033
또는 (b)
Figure PCTKR2012007964-appb-I000034
이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),
R 10 is (a)
Figure PCTKR2012007964-appb-I000033
Or (b)
Figure PCTKR2012007964-appb-I000034
E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
[화학식 3][Formula 3]
Figure PCTKR2012007964-appb-I000035
Figure PCTKR2012007964-appb-I000035
(식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
[화학식 4][Formula 4]
Figure PCTKR2012007964-appb-I000036
Figure PCTKR2012007964-appb-I000036
(식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
24. 위 10 내지 23 중 어느 한 항에 있어서, 상기 액정층은 이소시아네이트기 및 (메타)아크릴레이트기를 그 말단에 포함하는 접착력 강화제를 더 포함하여 형성된 것인 위상차 필름.24. The retardation film of any one of 10 to 23 above, wherein the liquid crystal layer is further formed by further comprising an adhesion enhancer including an isocyanate group and a (meth) acrylate group at its ends.
25. 위 24에 있어서, 상기 액정층과 상기 배향막은 서로 모두 포함하고 있는 상기 접착력 강화제 간의 탄소-탄소 포화결합을 포함하는 화학적 결합으로 접합된 위상차 필름.25. The retardation film of claim 24, wherein the liquid crystal layer and the alignment layer are bonded to each other by a chemical bond including a carbon-carbon saturated bond between the adhesion enhancer containing all of each other.
26. 위 24에 있어서, 상기 접착력 강화제는 하기 화학식 1 내지 4의 화합물로 이루어진 군에서 선택된 1종 이상의 것인 위상차 필름:26. The retardation film of claim 24, wherein the adhesion promoter is one or more selected from the group consisting of compounds of Formulas 1 to 4 below:
[화학식 1][Formula 1]
Figure PCTKR2012007964-appb-I000037
Figure PCTKR2012007964-appb-I000037
(식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
[화학식 2][Formula 2]
Figure PCTKR2012007964-appb-I000038
Figure PCTKR2012007964-appb-I000038
(식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R10는 (a)또는 (b)이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 10 is (a) or (b), E 1 and E 3 are each independently an alkyl group having 1 to 10 carbon atoms substituted or unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms, or an alkoxy group having 1 to 8 carbon atoms, E 2 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
[화학식 3][Formula 3]
Figure PCTKR2012007964-appb-I000039
Figure PCTKR2012007964-appb-I000039
(식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
[화학식 4][Formula 4]
Figure PCTKR2012007964-appb-I000040
Figure PCTKR2012007964-appb-I000040
(식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
27. 위 24에 있어서, 상기 액정층은 상기 액정성 화합물 100 중량부에 대하여 상기 접착력 강화제 0.1 내지 15 중량부를 포함하는 위상차 필름.27. In the above 24, wherein the liquid crystal layer retardation film containing 0.1 to 15 parts by weight of the adhesion strength enhancer based on 100 parts by weight of the liquid crystal compound.
본 발명의 배향막 형성용 조성물은 배향막으로 경화되는 과정에서 양 측면에 형성되는 서로 다른 층들과 화학적으로 결합을 형성하여 각 층간 접착력이 매우 높은 위상차 필름의 제조에 사용될 수 있다.The composition for forming an alignment film of the present invention may be used to prepare a retardation film having a very high adhesion between the layers by chemically forming bonds with different layers formed on both sides in the process of curing the alignment film.
또한, 본 발명의 위상차 필름은 층간 접착력이 매우 높기 때문에 이를 이용하여 편광필름과 같은 광학필름 제조 시에 박리 현상이 현저하게 감소하여 불량율이 낮으며 그에 따라 생산성을 향상할 수 있다.In addition, since the retardation film of the present invention has a very high interlayer adhesion, the peeling phenomenon is remarkably reduced in manufacturing an optical film such as a polarizing film using the retardation film, thereby lowering a defective rate and thus improving productivity.
도 1은 위상차 필름의 개략적인 단면도이다.1 is a schematic cross-sectional view of a retardation film.
본 발명은, 액정성 화합물을 배향시키기 위한 배향막을 형성하는 배향막 형성용 조성물로서, 상기 액정성 화합물의 반응성기와 결합될 수 있는 이소시아네이트기 및 (메타)아크릴레이트기를 그 말단에 포함하는 접착력 강화제를 포함함으로써, 배향막으로 경화되는 과정에서 측면에 형성되는 다른 층과 화학적으로 결합을 형성하여 층간 접착력이 매우 높은 위상차 필름의 제조에 사용되는 배향막 형성용 조성물에 관한 것이다.The present invention provides a composition for forming an alignment film for forming an alignment film for orienting a liquid crystal compound, the composition comprising an adhesion enhancing agent comprising an isocyanate group and a (meth) acrylate group at its terminals that can be bonded to a reactive group of the liquid crystal compound. The present invention relates to a composition for forming an alignment film used in the production of a retardation film having a very high interlayer adhesion by chemically forming a bond with another layer formed on the side surface in the process of curing the alignment film.
이하, 본 발명을 상세히 설명하기로 한다.Hereinafter, the present invention will be described in detail.
본 발명의 배향막 형성용 조성물은 배향막의 측면에 형성되는 다른 층과 화학적 결합을 할 수 있는 접착력 강화제를 포함하는 것을 특징으로 한다. 본 발명에 따른 접착력 강화제는 (메타)아크릴레이트기 말단 및 이소시아네이트기 말단을 각각 적어도 하나씩 포함한다. 본 발명에 있어서, (메타)아크릴레이트는 아크릴레이트 또는 메타아크릴레이트를 의미한다.The composition for forming an alignment film of the present invention is characterized by including an adhesion enhancing agent capable of chemically bonding with another layer formed on the side of the alignment film. The adhesion enhancer according to the present invention comprises at least one (meth) acrylate group terminal and one isocyanate group terminal. In the present invention, (meth) acrylate means acrylate or methacrylate.
본 발명에 있어서 접착력 강화제의 (메타)아크릴레이트기 및 이소시아네이트기는, 접착력 강화제가 배향막 형성용 조성물과 혼합되는 당시에는 (메타)아크릴레이트기 및/또는 이소시아네이트기를 말단에 포함하고 있지 않더라도, 액정성 화합물 및 기재와 화학적 결합을 하기 전에 추가적인 처리, 예를 들면 열처리와 같은 후처리를 통해 (메타)아크릴레이트기 또는 이소시아네이트기가 생성되는 작용기도 지칭하는 것으로 정의된다. 예를 들어, 열처리를 통해 이소시아네이트기가 생성되는 작용기로서, 접착력 강화제의 말단에 아미드 결합으로 연결된 피라졸기를 들 수 있다. 위 피라졸기는 열처리 과정을 통해 분리되고, 말단에 이소시아네이트기가 형성된다.In the present invention, the (meth) acrylate group and the isocyanate group of the adhesion enhancer are liquid crystalline compounds even if the (meth) acrylate group and / or the isocyanate group are not contained at the terminal at the time when the adhesion enhancer is mixed with the composition for forming an alignment film. And functional groups where (meth) acrylate groups or isocyanate groups are produced through further treatment, such as heat treatment, prior to chemical bonding with the substrate. For example, as a functional group in which an isocyanate group is produced through heat treatment, a pyrazole group connected by an amide bond to the terminal of the adhesion promoter may be mentioned. Gastric pyrazole groups are separated through a heat treatment process, an isocyanate group is formed at the end.
통상적으로 배향막은 액정의 배향을 유도하는 층으로서 위상차 필름 등에 사용되는 배향막은 그 일면은 액정층과 접촉하게 되고, 다른 일면은 기재 필름과 접촉하게 된다. 전술한 바와 같이, 종래에는 배향막과 배향막과 접촉하는 다른 층의 층간 접착력이 좋지 않아 문제점이 있었으나, 본 발명은 이소시아네이트기 및 (메타)아크릴레이트기를 그 말단에 포함하고 있는 접착력 강화제를 배향층에 도입하여, 위 이소시아네이트기 및 (메타)아크릴레이트기가 접촉하고 있는 액정층의 표면에 노출된 반응성기 및 보다 바람직하게는 기재 필름의 표면의 반응성기와 각각 화학적 결합을 함으로써 층간 접착력을 강화시킬 수 있다. Usually, an alignment film is a layer which induces alignment of liquid crystals, and an alignment film used for a retardation film or the like is in contact with the liquid crystal layer on one surface thereof and in contact with the base film on the other side thereof. As described above, conventionally, there was a problem in that the interlayer adhesion between the alignment layer and other layers in contact with the alignment layer was not good, but the present invention introduced an adhesion enhancing agent containing an isocyanate group and a (meth) acrylate group at its ends into the alignment layer. Thus, the interlayer adhesion may be enhanced by chemically bonding the reactive groups exposed on the surface of the liquid crystal layer to which the above isocyanate group and the (meth) acrylate group contact each other, and more preferably the reactive groups on the surface of the base film.
배향막의 일면과 접촉하는 액정층을 형성하는 액정성 화합물의 반응성기로는 탄소-탄소 불포화 결합, 수산기, 에폭시기, 시아노기 등을 예로 들 수 있으며, 바람직하게는 탄소-탄소 불포화 결합을 들 수 있다. 보다 구체적인 예로는 위 탄소-탄소 불포화 결합은, 아크릴로일옥시기, 시아노아크릴레이트기, 알릴기, 신나메이트기 또는 알릴옥시기에 포함된 탄소-탄소 불포화 결합일 수 있다.Examples of the reactive group of the liquid crystal compound forming the liquid crystal layer in contact with one surface of the alignment film include carbon-carbon unsaturated bonds, hydroxyl groups, epoxy groups, cyano groups, and the like, and preferably carbon-carbon unsaturated bonds. More specifically, the carbon-carbon unsaturated bond may be a carbon-carbon unsaturated bond included in an acryloyloxy group, cyanoacrylate group, allyl group, cinnamate group, or allyloxy group.
따라서, 당분야에서 사용되는 액정성 화합물 중에서 반응성기를 갖고 있는 기재라면 제한 없이 본 발명에서 사용될 수 있으며, 또한 당분야에서 통상적으로 사용되는 액정성 화합물이 그 자체로는 그러한 반응성기가 없더라도 당분야에 알려진 전처리 공정을 통해 말단에 반응성기가 도입될 수 있다면 제한 없이 본 발명에서 사용될 수 있다. Therefore, any base material having a reactive group among the liquid crystal compounds used in the art may be used in the present invention without limitation, and the liquid crystal compounds commonly used in the art may be known in the art even if they do not have such a reactive group. Any reactive group can be introduced at the end through the pretreatment process and can be used in the present invention without limitation.
보다 바람직하게는, 배향막의 다른 일면과 접촉하는 기재도 그 표면에 이소시아네이트기 또는 (메타)아크릴레이트기와 반응할 수 있는 반응성기를 가질 수 있다. 이러한 반응성기로는 수산기, 티올기, 카르복시기, (메타)아크릴레이트기, 아민기, 에폭시기 등을 예로 들 수 있다. More preferably, the substrate in contact with the other surface of the alignment film may also have a reactive group capable of reacting with an isocyanate group or a (meth) acrylate group on its surface. As such a reactive group, a hydroxyl group, a thiol group, a carboxy group, a (meth) acrylate group, an amine group, an epoxy group, etc. are mentioned.
따라서, 당분야에서 사용되는 기재 중에서 그러한 반응성기를 갖고 있는 기재라면 제한 없이 본 발명에서 사용될 수 있으며, 또한 당분야에서 통상적으로 사용되는 기재가 그 자체로는 그러한 반응성기가 없더라도 당분야에 알려진 표면처리 공정을 통해 표면에 반응성기가 도입될 수 있다면 제한 없이 본 발명에서 사용될 수 있다.Therefore, any substrate having such a reactive group among the substrates used in the art can be used in the present invention without limitation, and a substrate treatment process known in the art even if the substrate commonly used in the art does not have such a reactive group per se. If the reactive group can be introduced to the surface through may be used in the present invention without limitation.
본 발명에 따른 접착력 강화제의 보다 구체적인 예시는 하기 화학식 1, 화학식 2, 화학식 3 및 화학식 4로 표시되는 화합물로 이루어진 군에서 선택된 1종 이상인 것을 들 수 있다:More specific examples of the adhesion enhancer according to the present invention may be one or more selected from the group consisting of compounds represented by the following formula (1), (2), (3) and (4):
[화학식 1]  [Formula 1]
Figure PCTKR2012007964-appb-I000041
Figure PCTKR2012007964-appb-I000041
(식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
[화학식 2][Formula 2]
Figure PCTKR2012007964-appb-I000042
Figure PCTKR2012007964-appb-I000042
(식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R10는 (a)
Figure PCTKR2012007964-appb-I000043
또는 (b)
Figure PCTKR2012007964-appb-I000044
이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),
R 10 is (a)
Figure PCTKR2012007964-appb-I000043
Or (b)
Figure PCTKR2012007964-appb-I000044
E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
[화학식 3][Formula 3]
Figure PCTKR2012007964-appb-I000045
Figure PCTKR2012007964-appb-I000045
(식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
[화학식 4][Formula 4]
Figure PCTKR2012007964-appb-I000046
Figure PCTKR2012007964-appb-I000046
(식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
본 발명의 배향막 형성용 조성물에 있어서, 위 화학식 1 내지 화학식 4로 표시되는 접착력 강화제는 보다 우수한 층간 접착력을 확보하기 위해 화학식 2 내지 화학식 4로 표시되는 화합물 중 적어도 하나와 위 화학식 1로 표시되는 화합물의 혼합물로 사용될 수 있다.In the composition for forming an alignment layer of the present invention, the adhesion enhancer represented by Chemical Formula 1 to Chemical Formula 4 is at least one of the compounds represented by Chemical Formula 2 to Chemical Formula 4 and the compound represented by Chemical Formula 1 to secure better interlayer adhesion. It can be used as a mixture of.
위 화학식 1 내지 화학식 4의 접착력 강화제의 보다 구체적인 예시는 하기 화학식 5 내지 화학식 15로 표시되는 화합물로 이루어진 군에서 선택된 1종 이상인 것을 들 수 있다:More specific examples of the adhesion enhancer of Formula 1 to Formula 4 may include at least one selected from the group consisting of compounds represented by the following Formulas 5 to 15:
[화학식 5][Formula 5]
Figure PCTKR2012007964-appb-I000047
Figure PCTKR2012007964-appb-I000047
[화학식 6][Formula 6]
Figure PCTKR2012007964-appb-I000048
Figure PCTKR2012007964-appb-I000048
[화학식 7][Formula 7]
Figure PCTKR2012007964-appb-I000049
Figure PCTKR2012007964-appb-I000049
[화학식 8][Formula 8]
Figure PCTKR2012007964-appb-I000050
Figure PCTKR2012007964-appb-I000050
[화학식 9][Formula 9]
Figure PCTKR2012007964-appb-I000051
Figure PCTKR2012007964-appb-I000051
[화학식 10][Formula 10]
Figure PCTKR2012007964-appb-I000052
Figure PCTKR2012007964-appb-I000052
[화학식 11][Formula 11]
Figure PCTKR2012007964-appb-I000053
Figure PCTKR2012007964-appb-I000053
[화학식 12][Formula 12]
Figure PCTKR2012007964-appb-I000054
Figure PCTKR2012007964-appb-I000054
[화학식 13][Formula 13]
Figure PCTKR2012007964-appb-I000055
Figure PCTKR2012007964-appb-I000055
[화학식 14][Formula 14]
Figure PCTKR2012007964-appb-I000056
Figure PCTKR2012007964-appb-I000056
[화학식 15][Formula 15]
Figure PCTKR2012007964-appb-I000057
Figure PCTKR2012007964-appb-I000057
위 화학식 4로 표시되는 화합물 및 그 화합물의 예시인 위 화학식 12, 화학식 13, 화학식 14 및 화학식 15로 표시되는 화합물은 말단의 디메틸 피라졸기가 건조 공정 등의 열처리 과정을 통해 분리되고, 그에 따라 말단에 이소시아네이트기를 갖게 된다.Compounds represented by the above formula (4) and compounds represented by the above formulas (12), (13), (14) and (15), which are examples of the compounds, are separated from the terminal by dimethyl pyrazole group through a heat treatment process such as a drying process, and thus It will have an isocyanate group.
본 발명의 배향막 형성용 조성물은 위 접착력 강화제 외에 당분야에서 통상적으로 사용되는 광배향제, 광개시제 및 유기용매를 포함할 수 있다.The composition for forming an alignment layer of the present invention may include a photo-alignment agent, a photoinitiator and an organic solvent commonly used in the art in addition to the above adhesion enhancer.
광배향제로는 당분야에서 통상적으로 사용되는 광배향제가 특별한 제한 없이 사용될 수 있다. 예를 들면 신나메이트기를 포함하며 중량평균 분자량이 10,000-500,000 정도인 고분자가 사용될 수 있으나, 이에 한정되는 것은 아니다.As the photoalignment agent, a photoalignment agent conventionally used in the art may be used without particular limitation. For example, a polymer having a cinnamate group and having a weight average molecular weight of about 10,000-500,000 may be used, but is not limited thereto.
본 발명에 따른 접착력 강화제는 광배향제 100 중량부 대비 0.1 중량부 내지 20 중량부로 포함되는 것이 바람직하다. 위 범위에서 충분한 접착력을 확보할 수 있으며, 지나치게 과량으로 첨가되면 접착력은 개선되지만 광학필름에 적용시 다른 물성이 저하될 수 있다.Adhesion enhancers according to the present invention is preferably included in 0.1 to 20 parts by weight relative to 100 parts by weight of the photo-alignment agent. It is possible to secure sufficient adhesive strength in the above range, when excessively added, the adhesive strength is improved, but when applied to the optical film, other physical properties may be lowered.
광개시제로는 당분야에서 통상적으로 사용되는 광개시제가 특별한 제한 없이 사용될 수 있다. 예를 들면 트리아진계 화합물, 아세토페논계 화합물, 비이미다졸계 화합물, 옥심계 화합물, 벤조인계 화합물, 벤조페논계 화합물, 티오크산톤계 화합물, 안트라센계 화합물 등을 사용할 수 있으나, 이에 한정되는 것은 아니다.As the photoinitiator, photoinitiators conventionally used in the art may be used without particular limitation. For example, a triazine compound, an acetophenone compound, a biimidazole compound, an oxime compound, a benzoin compound, a benzophenone compound, a thioxanthone compound, an anthracene compound, etc. may be used, but is not limited thereto. no.
위 트리아진계 화합물로서는, 예를 들면 2,4-비스(트리클로로메틸)-6-(4-메톡시페닐)-1,3,5-트리아진, 2,4-비스 (트리클로로메틸)-6-(4-메톡시나프틸)-1,3,5-트리아진, 2,4-비스(트리클로로메틸)-6-피페로닐-1,3,5-트리아진, 2,4-비스(트리클로로메틸)-6-(4-메톡시스티릴)-1,3,5-트리아진, 2,4-비스(트리클로로메틸)-6-[2-(5-메틸퓨란-2-일)에테닐]-1,3,5-트리아진, 2,4-비스(트리클로로메틸)-6-[2-(퓨란-2-일)에테닐]-1,3,5-트리아진, 2,4-비스(트리 클로로메틸)-6-[2-(4-디에틸아미노-2-메틸페닐)에테닐]-1,3,5-트리아진, 2,4-비스(트리클로로메틸)-6-[2-(3,4-디메톡시페닐)에테닐]-1,3,5-트리아진 등을 들 수 있다.As the above triazine-based compound, for example, 2,4-bis (trichloromethyl) -6- (4-methoxyphenyl) -1,3,5-triazine, 2,4-bis (trichloromethyl)- 6- (4-methoxynaphthyl) -1,3,5-triazine, 2,4-bis (trichloromethyl) -6-piperonyl-1,3,5-triazine, 2,4- Bis (trichloromethyl) -6- (4-methoxystyryl) -1,3,5-triazine, 2,4-bis (trichloromethyl) -6- [2- (5-methylfuran-2 -Yl) ethenyl] -1,3,5-triazine, 2,4-bis (trichloromethyl) -6- [2- (furan-2-yl) ethenyl] -1,3,5-tri Azine, 2,4-bis (trichloromethyl) -6- [2- (4-diethylamino-2-methylphenyl) ethenyl] -1,3,5-triazine, 2,4-bis (trichloro Methyl) -6- [2- (3,4-dimethoxyphenyl) ethenyl] -1,3,5-triazine and the like.
위 아세토페논계 화합물로서는, 예를 들면, 디에톡시아세토페논, 2-히드록시-2-메틸-1-페닐프로판-1-온, 벤질디메틸케탈, 2-히드록시-1-[4-(2-히드록시에톡시)페닐]-2-메틸프로판-1-온, 1-히드록시시클로헥실페닐케톤, 2-메틸-1-(4-메틸티오페닐)-2-모르폴리노프로판-1-온, 2-벤질-2-디메틸아미노-1-(4-모르폴리노페닐)부탄-1-온, 2-히드록시-2-메틸-1-[4-(1-메틸비닐)페닐]프로판-1-온의 올리고머, 2-메틸-2-아미노(4-모르폴리노페닐)에탄-1-온, 2-에틸-2-아미노(4-모르폴리노페닐)에탄-1-온, 2-프로필-2-아미노(4-모르폴리노페닐)에탄-1-온, 2-부틸-2-아미노(4-모르폴리노페닐)에탄-1-온, 2-메틸-2-아미노(4-모르폴리노페닐)프로판-1-온,2-메틸-2-아미노(4-모르폴리노페닐)부탄-1-온, 2-에틸-2-아미노(4-모르폴리노페닐)프로판-1-온, 2-에틸-2-아미노(4-모르폴리노페닐)부탄-1-온, 2-메틸-2-메틸아미노(4-모르폴리노페닐)프로판-1-온, 2-메틸-2-디메틸아미노(4-모르폴리노페닐)프로판-1-온, 2-메틸-2-디에틸아미노(4-모르폴리노페닐)프로판-1-온 등을 들 수 있다.As the acetophenone-based compound, for example, diethoxyacetophenone, 2-hydroxy-2-methyl-1-phenylpropan-1-one, benzyl dimethyl ketal, 2-hydroxy-1- [4- (2 -Hydroxyethoxy) phenyl] -2-methylpropane-1-one, 1-hydroxycyclohexylphenyl ketone, 2-methyl-1- (4-methylthiophenyl) -2-morpholinopropane-1- On, 2-benzyl-2-dimethylamino-1- (4-morpholinophenyl) butan-1-one, 2-hydroxy-2-methyl-1- [4- (1-methylvinyl) phenyl] propane Oligomer of -1-one, 2-methyl-2-amino (4-morpholinophenyl) ethan-1-one, 2-ethyl-2-amino (4-morpholinophenyl) ethan-1-one, 2 -Propyl-2-amino (4-morpholinophenyl) ethan-1-one, 2-butyl-2-amino (4-morpholinophenyl) ethan-1-one, 2-methyl-2-amino (4 -Morpholinophenyl) propane-1-one, 2-methyl-2-amino (4-morpholinophenyl) butan-1-one, 2-ethyl-2-amino (4-morpholinophenyl) propane- 1-one, 2-ethyl-2-amino (4-morpholinophenyl) butan-1-one, 2-methyl-2-meth Amino (4-morpholinophenyl) propane-1-one, 2-methyl-2-dimethylamino (4-morpholinophenyl) propane-1-one, 2-methyl-2-diethylamino (4-mor Polynophenyl) propan-1-one etc. are mentioned.
위 비이미다졸계 화합물로서는, 예를 들면 2,2'-비스(2-클로로페닐)-4,4',5,5'-테트라페닐비이미다졸, 2,2'-비스(2,3-디클로로페닐)-4,4',5,5'-테트라페닐비이미다졸, 2,2'-비스(2-클로로페닐)-4,4',5,5'-테트라(알콕시페닐)비이미다졸, 2,2'-비스(2-클로로페닐)-4,4',5,5'-테트라(트리알콕시페닐)비이미다졸, 4,4',5,5' 위치의 페닐기가 카르보알콕시기에 의해 치환되어 있는 이미다졸 화합물 등을 들 수 있다. 이들 중에서 2,2'비스(2-클로로페닐)-4,4',5,5'-테트라 페닐비이미다졸, 2,2'-비스(2,3-디클로로페닐)-4,4',5,5'-테트라페닐비이미다졸이 바람직하게 사용된다.As the biimidazole-based compound, for example, 2,2'-bis (2-chlorophenyl) -4,4 ', 5,5'-tetraphenylbiimidazole, 2,2'-bis (2,3 -Dichlorophenyl) -4,4 ', 5,5'-tetraphenylbiimidazole, 2,2'-bis (2-chlorophenyl) -4,4', 5,5'-tetra (alkoxyphenyl) ratio Imidazole, 2,2'-bis (2-chlorophenyl) -4,4 ', 5,5'-tetra (trialkoxyphenyl) biimidazole, phenyl group at 4,4', 5,5 'position And imidazole compounds substituted with a boalkoxy group. Among these, 2,2'bis (2-chlorophenyl) -4,4 ', 5,5'-tetra phenylbiimidazole, 2,2'-bis (2,3-dichlorophenyl) -4,4', 5,5'-tetraphenylbiimidazole is preferably used.
위 옥심계 화합물로서는, 0-에톡시카르보닐-α-옥시이미노-1-페닐프로판-1-온 등을 들 수 있다.Examples of the above oxime compounds include 0-ethoxycarbonyl-α-oxyimino-1-phenylpropan-1-one and the like.
위 벤조인계 화합물로서는, 예를 들면, 벤조인, 벤조인메틸에테르, 벤조인에틸에테르, 벤조인이소프로필에테르, 벤조인이소부틸에테르 등을 들 수 있다.As said benzoin type compound, benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, benzoin isobutyl ether, etc. are mentioned, for example.
위 벤조페논계 화합물로서는, 예를 들면 벤조페논, 0-벤조일벤조산메틸, 4-페닐벤조페논, 4-벤조일-4'-메틸디페닐술피드, 3,3',4,4'-테트라(tert-부틸퍼옥시카르보닐)벤조페논, 2,4,6-트리메틸벤조페논 등을 들 수 있다.As the above benzophenone-based compound, for example, benzophenone, methyl 0-benzoylbenzoate, 4-phenylbenzophenone, 4-benzoyl-4'-methyldiphenyl sulfide, 3,3 ', 4,4'-tetra ( tert-butylperoxycarbonyl) benzophenone, 2,4,6-trimethylbenzophenone, etc. are mentioned.
위 티오크산톤계 화합물로서는, 예를 들면 2-이소프로필티오크산톤, 2,4-디에틸티오크산톤, 2,4-디클로로티오크산톤, 1-클로로-4-프로폭시티오크산톤 등을 들 수 있다.Examples of the thioxanthone-based compound include 2-isopropyl thioxanthone, 2,4-diethyl thioxanthone, 2,4-dichloro thioxanthone, 1-chloro-4-propoxy thioxanthone, and the like. Can be mentioned.
위 안트라센계 화합물로서는, 예를 들면 9,10-디메톡시안트라센, 2-에틸-9,10- 디메톡시안트라센, 9,10-디에톡시안트라센, 2-에틸-9,10-디에톡시안트라센 등을 들 수 있다.Examples of the anthracene-based compound include 9,10-dimethoxyanthracene, 2-ethyl-9,10-dimethoxyanthracene, 9,10-diethoxyanthracene, 2-ethyl-9,10-diethoxyanthracene, and the like. Can be mentioned.
이 외에도 2,4,6-트리메틸벤조일디페닐포스핀옥시드, 10-부틸-2-클로로아크리돈, 2-에틸안트라퀴논, 벤질, 9,10-페난트렌퀴논, 캄포퀴논, 페닐클리옥실산 메틸, 티타노센 화합물, 일본 특허 공표 2002-544205호 공보에 기재되어 있는 연쇄 이동을 일으킬 수 있는 기를 갖는 광중합 개시제 등을 들 수 있다.In addition, 2,4,6-trimethylbenzoyldiphenylphosphine oxide, 10-butyl-2-chloroacridone, 2-ethylanthraquinone, benzyl, 9,10-phenanthrenequinone, camphorquinone, phenylclioxylic acid Methyl, a titanocene compound, the photoinitiator which has group which can cause the chain transfer described in Unexamined-Japanese-Patent No. 2002-544205, etc. are mentioned.
본 발명의 배향막 형성용 조성물의 다른 측면에 있어서, 광개시제를 포함하지 않을 수 있다. 광개시제는 광배향제의 광중합 반응을 용이하게 해주는 장점이 있다. 다만, 광개시제는 과량으로 사용되는 경우에는 불순물로 작용하여 배향력을 떨어뜨리고 액정배향을 무너뜨려 교차편광시 빛샘현상을 발생시키거나 광경화후 개시제가 승화되어 mask를 오염시킬 수도 있으며, 노광시 광배향제가 반응하는 파장대비 개시제 반응파장의 Intensity가 대단히 높을 경우는 광배향을 시키기 위해서 Line speed를 떨어뜨리는 등 생산효율이 떨어지는 부작용이 발생할 수 있다. 이러한 측면에서, 본 발명의 배향막 형성용 조성물은 광개시제를 극소량 포함하거나 포함하지 않을 수도 있다.In another aspect of the composition for forming an alignment film of the present invention, it may not include a photoinitiator. Photoinitiators have the advantage of facilitating the photopolymerization reaction of the photo-alignment agent. However, when the photoinitiator is used in an excessive amount, it acts as an impurity, lowers the orientation force, breaks down the liquid crystal orientation, and may cause light leakage phenomenon during cross polarization, or the photoinitiator may be sublimated after photocuring to contaminate the mask. When the intensity of the initiator reaction wavelength is very high compared to the wavelength at which the reaction occurs, side effects may be reduced such as lowering the line speed for the optical alignment. In this aspect, the composition for forming an alignment film of the present invention may or may not contain a very small amount of photoinitiator.
유기용매로는 당분야에서 통상적으로 사용되는 유기용매가 특별한 제한 없이 사용될 수 있다. 예를 들면 에틸렌글리콜모노메틸에테르, 에틸렌글리콜모노에틸에테르, 에틸렌글리콜모노프로필에테르 및 에틸렌글리콜모노부틸에테르와 같은 에틸렌글리콜모노알킬에테르류; 디에틸렌글리콜디메틸에테르, 디에틸렌글리콜디에틸에테르, 디에틸렌글리콜에틸메틸에테르, 디에틸렌글리콜디프로필에테르, 디에틸렌글리콜디부틸에테르 등의 디에틸렌글리콜디알킬에테르류; 메틸셀로솔브아세테이트, 에틸셀로솔브아세테이트, 에틸렌글리콜모노부틸에테르아세테이트, 에틸렌글리콜모노에틸에테르아세테이트 등의 에틸렌글리콜알킬에테르아세테이트류; 프로필렌글리콜모노메틸에테르아세테이트, 프로필렌글리콜모노에틸에테르아세테이트, 프로필렌글리콜모노프로필에테르아세테이트, 메톡시부틸아세테이트, 메톡시펜틸아세테이트 등의 알킬렌글리콜알킬에테르아세테이트류; 프로필렌글리콜모노메틸에테르, 프로필렌글리콜모노에틸에테르, 프로필렌글리콜모노프로필에테르, 프로필렌글리콜모노부틸에테르 등의 프로필렌글리콜모노알킬에테르류; 프로필렌글리콜디메틸에테르, 프로필렌글리콜디에틸에테르, 프로필렌글리콜에틸메틸에테르, 프로필렌글리콜디프로필에테르프로필렌글리콜프로필메틸에테르, 프로필렌글리콜에틸프로필에테르 등의 프로필렌글리콜디알킬에테르류; 프로필렌글리콜메틸에테르프로피오네이트, 프로필렌글리콜에틸에테르프로피오네이트, 프로필렌글리콜프로필에테르프로피오네이트, 프로필렌글리콜부틸에테르프로피오네이트 등의 프로필렌글리콜알킬에테르프로피오네이트류; 메톡시부틸알코올, 에톡시부틸알코올, 프로폭시부틸알코올, 부톡시부틸알코올 등의 부틸디올모노알킬에테르류; 메톡시부틸아세테이트, 에톡시부틸아세테이트, 프로폭시부틸아세테이트, 부톡시부틸아세테이트 등의 부탄디올모노알킬에테르아세테이트류; 메톡시부틸프로피오네이트, 에톡시부틸프로피오네이트, 프로폭시부틸프로피오네이트, 부톡시부틸프로피오네이트 등의 부탄디올모노알킬에테르프로피오네이트류; 디프로필렌글리콜디메틸에테르, 디프로필렌글리콜디에틸에테르, 디프로필렌글리콜메틸에틸에테르 등의 디프로필렌글리콜디알킬에테르류; 벤젠, 톨루엔, 자일렌, 메시틸렌 등의 방향족 탄화수소류; 메틸에틸케톤, 아세톤, 메틸아밀케톤, 메틸이소부틸케톤, 시클로헥사논 등의 케톤류; 에탄올, 프로판올, 부탄올, 헥산올, 시클로헥산올, 에틸렌글리콜, 글리세린 등의 알코올류; 아세트산메틸, 아세트산에틸, 아세트산프로필, 아세트산부틸, 2-히드록시프로피온산에틸, 2-히드록시-2-메틸프로피온산메틸, 2-히드록시-2-메틸프로피온산에틸, 히드록시아세트산메틸, 히드록시아세트산에틸, 히드록시아세트산부틸, 락트산메틸, 락트산에틸, 락트산프로필, 락트산부틸, 3-히드록시프로피온산메틸, 3-히드록시프로피온산에틸, 3-히드록시프로피온산프로필, 3-히드록시프로피온산부틸, 2-히드록시-3-메틸부탄산메틸, 메톡시아세트산메틸, 메톡시아세트산에틸, 메톡시아세트산프로필, 메톡시아세트산부틸, 에톡시아세트산메틸, 에톡시아세트산에틸, 에톡시아세트산프로필, 에톡시아세트산부틸, 프로폭시아세트산메틸, 프로폭시아세트산에틸, 프로폭시아세트산프로필, 프로폭시아세트산부틸, 부톡시아세트산메틸, 부톡시아세트산에틸, 부톡시아세트산프로필, 부톡시아세트산부틸, 2-메톡시프로피온산메틸, 2-메톡시프로피온산에틸, 2-메톡시프로피온산프로필, 2-메톡시프로피온산부틸, 2-에톡시프로피온산메틸, 2-에톡시프로피온산에틸, 2-에톡시프로피온산프로필, 2-에톡시프로피온산부틸, 2-부톡시프로피온산메틸, 2-부톡시프로피온산에틸, 2-부톡시프로피온산프로필, 2-부톡시프로피온산부틸, 3-메톡시프로피온산메틸, 3-메톡시프로피온산에틸, 3-메톡시프로피온산프로필, 3-메톡시프로피온산부틸, 3-에톡시프로피온산메틸, 3-에톡시프로피온산에틸, 3-에톡시프로피온산프로필, 3-에톡시프로피온산부틸, 3-프로폭시프로피온산메틸, 3-프로폭시프로피온산에틸, 3-프로폭시프로피온산프로필, 3-프로폭시프로피온산부틸, 3-부톡시프로피온산메틸, 3-부톡시프로피온산에틸, 3-부톡시프로피온산프로필, 3-부톡시프로피온산부틸 등의 에스테르류; 테트라히드로푸란, 피란 등의 고리형 에테르류; γ-부티로락톤 등의 고리형 에스테르류 등을 각각 단독으로 또는 2종 이상을 혼합하여 사용할 수 있다.As the organic solvent, an organic solvent conventionally used in the art may be used without particular limitation. Ethylene glycol monoalkyl ethers such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether and ethylene glycol monobutyl ether; Diethylene glycol dialkyl ethers such as diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol ethyl methyl ether, diethylene glycol dipropyl ether and diethylene glycol dibutyl ether; Ethylene glycol alkyl ether acetates such as methyl cellosolve acetate, ethyl cellosolve acetate, ethylene glycol monobutyl ether acetate, and ethylene glycol monoethyl ether acetate; Alkylene glycol alkyl ether acetates such as propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, propylene glycol monopropyl ether acetate, methoxy butyl acetate, and methoxy pentyl acetate; Propylene glycol monoalkyl ethers such as propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monopropyl ether, and propylene glycol monobutyl ether; Propylene glycol dialkyl ethers such as propylene glycol dimethyl ether, propylene glycol diethyl ether, propylene glycol ethyl methyl ether, propylene glycol dipropyl ether propylene glycol propyl methyl ether and propylene glycol ethyl propyl ether; Propylene glycol alkyl ether propionates such as propylene glycol methyl ether propionate, propylene glycol ethyl ether propionate, propylene glycol propyl ether propionate and propylene glycol butyl ether propionate; Butyl diol monoalkyl ethers such as methoxy butyl alcohol, ethoxy butyl alcohol, propoxy butyl alcohol and butoxy butyl alcohol; Butanediol monoalkyl ether acetates such as methoxy butyl acetate, ethoxy butyl acetate, propoxy butyl acetate and butoxy butyl acetate; Butanediol monoalkyl ether propionates such as methoxybutyl propionate, ethoxybutyl propionate, propoxybutyl propionate and butoxybutyl propionate; Dipropylene glycol dialkyl ethers such as dipropylene glycol dimethyl ether, dipropylene glycol diethyl ether, and dipropylene glycol methyl ethyl ether; Aromatic hydrocarbons such as benzene, toluene, xylene and mesitylene; Ketones such as methyl ethyl ketone, acetone, methyl amyl ketone, methyl isobutyl ketone and cyclohexanone; Alcohols such as ethanol, propanol, butanol, hexanol, cyclohexanol, ethylene glycol, glycerin; Methyl acetate, ethyl acetate, propyl acetate, butyl acetate, 2-hydroxypropionate, methyl 2-hydroxy-2-methylpropionate, 2-hydroxy-2-methylpropionate, methyl hydroxyacetate, ethyl hydroxyacetate , Butyl hydroxy acetate, methyl lactate, ethyl lactate, propyl lactate, butyl lactate, 3-hydroxypropionate methyl, 3-hydroxypropionate ethyl, 3-hydroxypropionate propyl, 3-hydroxypropionate butyl, 2-hydroxy 3-Methyl methyl butyrate, methyl methoxy acetate, ethyl methoxy acetate, methoxy acetate propyl, butyl acetate, ethoxy acetate methyl, ethoxy acetate, ethoxy acetate propyl, butyl ethoxy acetate, propoxy Methyl acetate, ethyl propoxy acetate, propyl propoxy acetate, butyl propoxy acetate, methyl butoxy acetate, ethyl butoxy acetate, Propyl acetate, butyl butoxy acetate, methyl 2-methoxypropionate, 2-methoxy ethylpropionate, propyl 2-methoxypropionate, butyl 2-methoxypropionate, methyl 2-ethoxypropionate, ethyl 2-ethoxypropionate Propyl 2-ethoxypropionate, butyl 2-ethoxypropionate, methyl 2-butoxypropionate, ethyl 2-butoxypropionate, propyl 2-butoxypropionate, butyl 2-butoxypropionate, methyl 3-methoxypropionate, 3-methoxy ethylpropionate, 3-methoxy propylpropionate, 3-methoxy propylpropionate, 3-ethoxy propylpropionate, 3-ethoxy propylpropionate, 3-ethoxy propylpropionate, 3-ethoxy propylpropionate, 3 Methyl propoxypropionate, 3-propoxy propionate, 3-propoxypropionate, butyl 3-propoxypropionate, methyl 3-butoxypropionate, ethyl 3-butoxypropionate, 3-butoxypropionic acid Esters such as ropil, 3-butoxy-propionic acid butyl; Cyclic ethers such as tetrahydrofuran and pyran; Cyclic esters, such as (gamma) -butyrolactone, etc. can be used individually or in mixture of 2 or more types, respectively.
본 발명의 배향막 형성용 조성물은 필요에 따라 충진제, 경화제, 레벨링제, 밀착촉진제, 산화 방지제, 자외선 흡수제, 응집 방지제, 연쇄 이동제 등의 첨가제를 더 포함할 수 있다. The composition for forming an alignment film of the present invention may further include additives such as fillers, curing agents, leveling agents, adhesion promoters, antioxidants, ultraviolet absorbers, anti-aggregation agents, chain transfer agents and the like, as necessary.
본 발명의 배향막 형성용 조성물은 경화공정을 거쳐 배향막을 형성하며, 통상적으로 사용되는 배향막이 사용되는 분야라면 제한없이 적용될 수 있다. 바람직하게는, 3차원 화상표시에 사용되는 디스플레이 장치에 구비되는 패턴화된 위상차 필름(패턴화된 리타더)에 유용하게 사용될 수 있다.The composition for forming an alignment film of the present invention forms an alignment film through a curing process, and may be applied without limitation as long as a conventionally used alignment film is used. Preferably, it can be usefully used for the patterned retardation film (patterned retarder) provided in the display apparatus used for three-dimensional image display.
통상적인 위상차 필름의 구조를 도 1에 도시하였다. 위상차 필름(100)은 투명 기재(110)와 광경화 액정층(120) 사이에 배향막(130)이 개재된 구조를 갖는다.The structure of a conventional retardation film is shown in FIG. The retardation film 100 has a structure in which an alignment layer 130 is interposed between the transparent substrate 110 and the photocurable liquid crystal layer 120.
본 발명에 따른 투명 기재(110)는 바람직하게는 표면에 수산기, 티올기, 카르복시기, (메타)아크릴레이트기, 아민기 또는 에폭시기와 같은, 이소시아네이트기 또는 (메타)아크릴레이트기와 반응할 수 있는 반응성기를 가질 수 있다.The transparent substrate 110 according to the present invention is preferably reactive to react with isocyanate groups or (meth) acrylate groups, such as hydroxyl groups, thiol groups, carboxyl groups, (meth) acrylate groups, amine groups or epoxy groups on the surface. It may have a group.
본 발명에 따른 투명 기재(110)는 당분야에서 통상적으로 사용되는 기재 중에서 위와 같은 반응성기를 갖는 기재라면 제한 없이 사용될 수 있으며, 또한 그러한 반응성기가 없더라도 당분야에 알려진 전처리 공정을 통해 표면에 반응성기가 도입될 수 있다면 제한 없이 본 발명에서 사용될 수 있다.The transparent substrate 110 according to the present invention may be used without limitation as long as it is a substrate having such a reactive group among substrates commonly used in the art, and even without such a reactive group, the reactive group is introduced to the surface through a pretreatment process known in the art. If possible, it can be used in the present invention without limitation.
당분야에서 기재로는 통상적으로 투명한 필름이 사용되며, 예를 들면 TAC(triacetyl cellulose)계, COP(cyclo-olefin polymer)계, PMMA(poly (methyl methacrylate))계 중합체 등을 포함하는 필름이다. TAC, COP, PMMA로 제조된 기재는 그 표면에 이소시아네이트 또는 (메타)아크릴레이트와 반응할 수 있는 반응성기를 갖고 있지 않다. 따라서, 표면처리를 통해 표면에 반응성기를 도입할 수 있는데, 수산기를 예로 설명하면, TAC 표면에 검화(safonification) 처리를 하면 표면에 수산기가 도입되며, COP의 표면에 플라즈마 처리를 하면 표면에 수산기가 도입될 수 있다. 이 외에 다른 표면처리로는 코로나 처리, 프라이머 처리 등의 건식 처리; 검화 처리를 포함하는 알칼리 처리 등의 화학 처리; 용이한 접착제층을 형성하는 코팅 처리 등을 들 수 있다. 바람직하기로는 셀룰로오스계 필름은 검화 처리를 포함하는 알칼리 처리; 아크릴계, 폴리올레핀계 및 폴리에스테르계 필름은 코로나 처리 또는 플라즈마 처리 등의 건식 처리가 유리하다. 상기 플라즈마 처리의 보다 구체적인 예로는, 원격 플라즈마(Remote plasma), 직접 플라즈마(Direct plasma), 단량체 플라즈마(Monomer plasma) 중에서 적어도 한 공정이상을 실시할 수 있다.As a substrate in the art, a transparent film is generally used. For example, a film including a triacetyl cellulose (TAC), a cyclo-olefin polymer (COP), a poly (methyl methacrylate) polymer, or the like is used. Substrates made of TAC, COP, PMMA do not have reactive groups on their surface that can react with isocyanates or (meth) acrylates. Therefore, the reactive group can be introduced to the surface through surface treatment. When the hydroxyl group is described as an example, the hydroxyl group is introduced to the surface when the saponification treatment is performed on the TAC surface, and the hydroxyl group is applied to the surface when the plasma treatment is performed on the surface of the COP. Can be introduced. Other surface treatments include dry treatments such as corona treatment and primer treatment; Chemical treatment such as alkali treatment including saponification treatment; The coating process etc. which form an easy adhesive bond layer is mentioned. Preferably, the cellulose-based film is alkali treatment including saponification treatment; Acrylic, polyolefin and polyester films are advantageous for dry treatment such as corona treatment or plasma treatment. As a more specific example of the plasma treatment, at least one process may be performed among a remote plasma, a direct plasma, and a monomer plasma.
광경화 액정층(120)은 말단에 탄소-탄소 불포화 탄소 결합, 수산기, 에폭시기 또는 시아노기를 갖는 액정성 화합물, 중합 개시제 및 유기용매를 포함하는 조성물을 경화시켜 제조되며, 중합 개시제로는 당분야에서 통상적으로 사용하는 광중합 개시제 또는 열중합 개시제가 사용될 수 있고, 광중합 개시제로는 앞서 예시한 광개시제가 사용될 수 있다. 유기 용매 역시 앞서 예시한 유기 용매 중에서 적절하게 선택하여 사용할 수 있다.The photocurable liquid crystal layer 120 is prepared by curing a composition comprising a liquid crystal compound having a carbon-carbon unsaturated carbon bond, a hydroxyl group, an epoxy group or a cyano group, a polymerization initiator, and an organic solvent at the end thereof, In general, a photopolymerization initiator or a thermal polymerization initiator may be used, and the photoinitiator exemplified above may be used as the photopolymerization initiator. An organic solvent may also be appropriately selected from among the organic solvents exemplified above.
본 발명의 다른 측면에 있어서, 필요에 따라, 광경화 액정층(20)를 형성하기 위한 상기 조성물은 전술한 본 발명에 따른 접착력 강화제를 더 포함할 수 있다. 이 경우 액정층과 배향막이 서로 모두 포함하고 있는 이소시아네이트기 및 (메타)아크릴레이트기를 그 말단에 포함하는 접착력 강화제 사이에 탄소-탄소 포화결합이 형성됨으로써, 층간 접착력을 더욱 향상시킬 수 있는 측면에서 보다 바람직하다. 이 경우 접착력 강화제의 함량은, 상기 액정성 화합물 100 중량부에 대하여 상기 접착력 강화제 0.1 내지 15 중량부를 포함하는 것이 기재와 배향막 사이 및 배향막과 액정층 사이의 밀착력을 강화시키는 효과를 효과적으로 발휘하면서도 액정 배향성을 유지하고 위상차를 저하시키지 않는 측면에서 바람직하다.In another aspect of the present invention, if necessary, the composition for forming the photocurable liquid crystal layer 20 may further include an adhesion enhancer according to the present invention described above. In this case, a carbon-carbon saturated bond is formed between the isocyanate group and the (meth) acrylate group containing both of the liquid crystal layer and the alignment layer at the end thereof, so that the adhesion between the layers can be further improved. desirable. In this case, the content of the adhesion enhancing agent, while containing 0.1 to 15 parts by weight of the adhesion enhancing agent with respect to 100 parts by weight of the liquid crystal compound effectively exerts the effect of strengthening the adhesion between the substrate and the alignment film and between the alignment film and the liquid crystal layer, the liquid crystal orientation It is preferable in terms of maintaining and not lowering the phase difference.
본 발명에 있어서, 투명 기재(110)와 광경화 액정층(120)의 표면에 노출된 반응성기는 서로 동일할 수도 있고, 다를 수도 있다.In the present invention, the reactive groups exposed on the surfaces of the transparent substrate 110 and the photocurable liquid crystal layer 120 may be the same or different.
본 발명에 따른 배향막(130)은 투명 기재(110) 표면의 반응성기 및 광경화 액정층(120) 표면에 노출된 액정성 화합물의 반응성기와 반응하여 화학적 결합을 형성할 수 있는 이소시아네이트기 및 (메타)아크릴레이트기를 말단에 포함하는 접착력 강화제를 포함한다.The alignment layer 130 according to the present invention is an isocyanate group capable of forming a chemical bond by reacting with a reactive group on the surface of the transparent substrate 110 and a reactive group of the liquid crystal compound exposed on the surface of the photocurable liquid crystal layer 120 and a (meth) ) Adhesion enhancer comprising an acrylate group at the end.
화학적 결합의 구체적인 예를 들면, 접착력 강화제의 이소시아네이트 말단은 투명 기재(110) 또는 광경화 액정층(120)의 수산기, 티올기, 카르복시기, 아민기, 에폭시기 또는 시아노기와 반응하여 우레탄 결합을 형성할 수 있다. As a specific example of the chemical bond, the isocyanate end of the adhesion promoter may react with the hydroxyl group, thiol group, carboxyl group, amine group, epoxy group or cyano group of the transparent substrate 110 or the photocurable liquid crystal layer 120 to form a urethane bond. have.
상기 수산기, 티올기, 카르복시기, 아민기, 에폭시기 또는 시아노기가 이소시아네이트기와 반응하여 우레탄 결합을 형성하는 반응식은 다음과 같다. 참고로, 시아노기는 가열하면서 H2O로 전처리하여 아민기 또는 카르복시산으로 변형시켜 이소시아네이트기와 반응시킬 수 있다.The hydroxyl, thiol, carboxyl, amine, epoxy or cyano group reacts with the isocyanate group to form a urethane bond as follows. For reference, the cyano group may be pretreated with H 2 O while being heated, transformed into an amine group or carboxylic acid, and reacted with an isocyanate group.
[반응식 1]Scheme 1
Figure PCTKR2012007964-appb-I000058
Figure PCTKR2012007964-appb-I000058
[반응식 2]Scheme 2
Figure PCTKR2012007964-appb-I000059
Figure PCTKR2012007964-appb-I000059
[반응식 3]Scheme 3
Figure PCTKR2012007964-appb-I000060
Figure PCTKR2012007964-appb-I000060
[반응식 4]Scheme 4
Figure PCTKR2012007964-appb-I000061
Figure PCTKR2012007964-appb-I000061
[반응식 5]Scheme 5
Figure PCTKR2012007964-appb-I000062
Figure PCTKR2012007964-appb-I000062
[반응식6]Scheme 6
Figure PCTKR2012007964-appb-I000063
Figure PCTKR2012007964-appb-I000063
화학적 결합의 구체적인 다른 예를 들면, 배향막의 접착력 강화제의 (메타)아크릴레이트 말단은 투명 기재(110) 또는 광경화 액정층(120)의 (메타)아크릴레이트기, 탄소-탄소 불포화 결합과 반응하여 탄소-탄소 포화 결합을 형성할 수 있다. 또한, 전술한 바와 같이 액정층(120)이 접착력 강화제를 포함하는 경우에는 배향막의 접착력 강화제와 액정층의 접착력 강화제의 각 (메타)아크릴레이트 말단이 반응하여 탄소-탄소 포화 결합을 형성할 수 있다.As another specific example of the chemical bond, the (meth) acrylate end of the adhesion enhancing agent of the alignment layer reacts with the (meth) acrylate group and the carbon-carbon unsaturated bond of the transparent substrate 110 or the photocurable liquid crystal layer 120 It may form a carbon-carbon saturated bond. In addition, as described above, when the liquid crystal layer 120 includes an adhesion enhancer, each (meth) acrylate terminal of the adhesion enhancer of the alignment layer and the adhesion enhancer of the liquid crystal layer may react to form a carbon-carbon saturated bond. .
화학적 결합의 구체적인 다른 예를 들면, 접착력 강화제의 (메타)아크릴레이트 말단은 투명 기재(110)의 티올기와 반응하여 티올렌 결합을 형성할 수 있다.As another specific example of the chemical bond, the (meth) acrylate end of the adhesion enhancer may react with the thiol group of the transparent substrate 110 to form a thiylene bond.
이러한 우레탄 결합, 탄소-탄소 포화 결합, 티올렌 결합 등의 화학적 결합을 통해 본 발명의 배향막(130)은 투명 기재(110) 및 광경화 액정층(120)과 높은 접착력으로 부착되게 된다.Through the chemical bonding such as a urethane bond, a carbon-carbon saturated bond, a thiylene bond, and the like, the alignment layer 130 of the present invention is attached to the transparent substrate 110 and the photocurable liquid crystal layer 120 with high adhesion.
본 발명에 따른 위상차 필름은 투명 기재 상에 본 발명에 따른 배향막 조성물을 도포한 후 건조하고 노광하여 배향막에 패턴을 형성한 다음, 위 배향막에 광경화 액정층 형성용 조성물을 도포하고 건조한 후 광경화 공정을 수행하여 제조할 수 있다. 전술한 바와 같이, 본 발명에 따른 배향막과 액정층의 화학적 결합은 액정층의 경화 공정에서 이루어지며, 배향막과 투명 기재와의 화학적 결합은 건조 공정(열처리)에서 이루어진다.The retardation film according to the present invention is applied to the alignment layer composition according to the invention on a transparent substrate and then dried and exposed to form a pattern on the alignment layer, and then the photocurable liquid crystal layer forming composition on the alignment layer and dried photocurable It can be prepared by carrying out the process. As described above, the chemical bonding of the alignment film and the liquid crystal layer according to the present invention is made in the curing process of the liquid crystal layer, and the chemical bonding of the alignment film and the transparent substrate is made in a drying process (heat treatment).
이하, 본 발명을 구체적으로 설명하기 위해 실시예를 들어 상세하게 설명하기로 한다. 그러나, 본 발명에 따른 실시예는 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 아래에서 상술하는 실시예에 한정되는 것으로 해석되어서는 안 된다. 본 발명의 실시예는 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해서 제공되는 것이다.Hereinafter, the present invention will be described in detail with reference to Examples. However, embodiments according to the present invention can be modified in many different forms, the scope of the present invention should not be construed as limited to the embodiments described below. The embodiments of the present invention are provided to more completely explain the present invention to those skilled in the art.
실시예 1-7 및 비교예 1-2Example 1-7 and Comparative Example 1-2
하기 표 1에 기재된 조성으로 광배향제, 접착력 강화제, 광개시제(Irgacure 907, BASF사 제조), 유기용매(톨루엔)를 혼합하여 배향막 형성용 조성물을 제조하였다(단위: g).A composition for forming an alignment layer was prepared by mixing a photo-alignment agent, an adhesion enhancing agent, a photoinitiator (Irgacure 907, manufactured by BASF) and an organic solvent (toluene) in the composition shown in Table 1 below (unit: g).
표 1
Figure PCTKR2012007964-appb-T000001
Table 1
Figure PCTKR2012007964-appb-T000001
시료 제조Sample manufacturing
제조된 실시예 1-7 및 비교예 1-2의 조성물을 검화 처리하여 표면에 수산기가 도입된 Fuji사의 TAC Film에 도포하고 100℃에서 1분간 건조를 실시한 후, 노광을 각각 실시하여 배향막을 생성하였다. 위 배향막 상에 말단에 탄소-탄소 불포화 결합을 갖는 액정성 화합물을 포함하는 광경화형 액정 조성물(RMS)을 도포하고 60℃의 온도에서 1분간 건조시킨 후, 노광하여 경화반응을 유도하여 위상차 필름을 제조하였다.The compositions of Examples 1-7 and Comparative Examples 1-2 prepared were saponified and applied to Fuji TAC Film having a hydroxyl group introduced thereon, dried at 100 ° C. for 1 minute, and then subjected to exposure to produce alignment films. It was. Applying a photocurable liquid crystal composition (RMS) comprising a liquid crystal compound having a carbon-carbon unsaturated bond on the terminal on the upper alignment layer and dried at a temperature of 60 ℃ for 1 minute, and then exposed to induce a curing reaction to give a retardation film Prepared.
실시예 8-14 및 비교예 3-4Example 8-14 and Comparative Example 3-4
하기 표 2에 기재된 조성으로 액정성 화합물(RMS), 접착력 강화제, 광개시제(Irgacure 907, BASF사 제조), 유기 용매(톨루엔)을 혼합하여 액정층 형성용 조성물을 제조하였다(단위: g). A liquid crystal compound (RMS), an adhesion enhancing agent, a photoinitiator (Irgacure 907, manufactured by BASF), and an organic solvent (toluene) were mixed in the composition shown in Table 2 to prepare a composition for forming a liquid crystal layer (unit: g).
또한, 하기 표 2에 기재된 조성으로 광배향제, 접착력 강화제, 광개시제(Irgacure 907, BASF사 제조), 유기용매(톨루엔)를 혼합하여 배향막 형성용 조성물을 제조하였다(단위: g).In addition, a photo-alignment agent, an adhesion enhancing agent, a photoinitiator (Irgacure 907, manufactured by BASF) and an organic solvent (toluene) were mixed with the composition shown in Table 2 to prepare an alignment film-forming composition (unit: g).
표 2
Figure PCTKR2012007964-appb-T000002
TABLE 2
Figure PCTKR2012007964-appb-T000002
시료 제조Sample manufacturing
검화 처리하여 표면에 히드록시기가 도입된 Fuji사의 TAC Film에 상기 실시예 8-14 및 비교예 3-4의 배향막 형성용 조성물을 도포하고 100℃에서 1분간 건조를 실시한 후, 노광을 각각 실시하여 배향막을 생성하였다. 위 배향막 상에 상기 실시예 8-14 및 비교예 3-4의 액정층 형성용 조성물을 도포하고 60℃의 온도에서 1분간 건조시킨 후, 노광하여 경화반응을 유도하여 위상차 필름을 제조하였다.Apply the alignment film forming composition of Example 8-14 and Comparative Example 3-4 to Fuji TAC film having a hydroxyl group introduced to the surface by saponification, and dried at 100 ° C. for 1 minute, followed by exposure to each alignment film. Produced. The composition for forming a liquid crystal layer of Example 8-14 and Comparative Example 3-4 was coated on the alignment layer and dried at a temperature of 60 ° C. for 1 minute, and then exposed to induce a curing reaction to prepare a retardation film.
시험예Test Example
<배향각><Orientation angle>
루케오사의 WPA-100L 장비로 제조된 위상차 필름의 A, B Pattern중 A의 배향각을 측정하였다 The orientation angles of A in the A and B patterns of the retardation film manufactured by the Wake-100L equipment of Lukeo Corp. were measured.
◎ ; 45° ± 3 (A pattern 경우) , 135° ± 3 (B pattern 경우)◎; 45 ° ± 3 (A pattern), 135 ° ± 3 (B pattern)
○ : 45° ± 6 미만 (A pattern 경우) , 135° ± 6 미만 (B pattern 경우)○: Less than 45 ° ± 6 (A pattern), Less than 135 ° ± 6 (B pattern)
X : 45° ± 6 이상 (A pattern 경우) , 135° ± 6 이상 (B pattern 경우)X: 45 ° ± 6 or more (A pattern), 135 ° ± 6 or more (B pattern)
<위상차><Phase difference>
Rr ; 비교예1(표 3) 또는 비교예 3(표 4)에서 제조된 위상차 필름의 위상차Rr; Retardation of the retardation film prepared in Comparative Example 1 (Table 3) or Comparative Example 3 (Table 4)
Rs ; 당해 위상차 필름의 위상차 Rs; Retardation of the retardation film
◎ ; 0.97 < Rs/Rr < 1.03◎; 0.97 <Rs / Rr <1.03
○ : 0.95 < Rs/Rr < 0.97 또는 1.03 < Rs/Rr < 1.05○: 0.95 <Rs / Rr <0.97 or 1.03 <Rs / Rr <1.05
△ : 0.90 < Rs/Rr < 0.95 또는 1.05 < Rs/Rr < 1.1△: 0.90 <Rs / Rr <0.95 or 1.05 <Rs / Rr <1.1
× : Rs/Rr 1.1 이상 또는 Rs/Rr 0.90 이하×: Rs / Rr 1.1 or more or Rs / Rr 0.90 or less
<층간 접착력><Layer adhesion>
생성된 패턴을 광학현미경을 통하여 평가하였을 때 아래와 같은 패턴상에 뜯김 현상 정도로 평가하였다. When the generated pattern was evaluated through an optical microscope, the degree of tearing was evaluated on the following pattern.
◎ ; 패턴상 뜯김 없음◎; No tearing on the pattern
○ : 패턴상 뜯김 1~3개○: 1 to 3 tearing patterns
△ : 패턴상 뜯김 4~8개△: 4 to 8 tears on the pattern
× : 패턴상 뜯김 8개 초과×: more than 8 tears in pattern
표 3
평가항목 실시예 비교예
1 2 3 4 5 6 7 1 2
배향각(A 패턴)
배향각(B 패턴)
위상차(A 패턴)
위상차(B 패턴)
층간 접착력 × ×
TABLE 3
Evaluation item Example Comparative example
One 2 3 4 5 6 7 One 2
Orientation Angle (A Pattern)
Orientation Angle (B Pattern)
Phase difference (A pattern)
Phase difference (B pattern)
Interlayer adhesion × ×
표 4
평가항목 실시예 비교예
8 9 10 11 12 13 14 3 4
배향각(A 패턴)
배향각(B 패턴)
위상차(A 패턴)
위상차(B 패턴)
층간 접착력 × ×
Table 4
Evaluation item Example Comparative example
8 9 10 11 12 13 14 3 4
Orientation Angle (A Pattern)
Orientation Angle (B Pattern)
Phase difference (A pattern)
Phase difference (B pattern)
Interlayer adhesion × ×
위 표 3 및 4에 기재된 바와 같이, 본 발명에 따른 실시예들의 위상차 필름은 비교예들의 위상차필름과 동일하거나 유사한 광학적 성능을 발휘하지만, 층간 접착력은 비교예들보다 우수한 것을 알 수 있다.As described in Tables 3 and 4 above, the retardation film of the embodiments according to the present invention exhibits the same or similar optical performance as the retardation film of the comparative examples, it can be seen that the interlayer adhesion is superior to the comparative examples.

Claims (27)

  1. 액정성 화합물을 배향시키기 위한 배향막을 형성하는 배향막 형성용 조성물로서, 상기 액정성 화합물의 반응성기와 결합될 수 있는 이소시아네이트기 및 (메타)아크릴레이트기를 그 말단에 포함하는 접착력 강화제를 포함하는 배향막 형성용 조성물.An alignment film forming composition for forming an alignment film for orienting a liquid crystalline compound, the composition for forming an alignment film comprising an adhesion enhancing agent including an isocyanate group and a (meth) acrylate group at its terminals that may be bonded to a reactive group of the liquid crystal compound. Composition.
  2. 청구항 1에 있어서, 상기 액정성 화합물의 반응성기는 탄소-탄소 불포화 결합, 수산기, 에폭시기 또는 시아노기인 배향막 형성용 조성물.The composition for forming an alignment film according to claim 1, wherein the reactive group of the liquid crystal compound is a carbon-carbon unsaturated bond, a hydroxyl group, an epoxy group, or a cyano group.
  3. 청구항 1에 있어서, 상기 접착력 강화제는 하기 화학식 1 내지 4의 화합물로 이루어진 군에서 선택된 1 종 이상의 것인 배향막 형성용 조성물:The composition of claim 1, wherein the adhesion enhancer is at least one selected from the group consisting of compounds of Formulas 1 to 4:
    [화학식 1][Formula 1]
    Figure PCTKR2012007964-appb-I000064
    Figure PCTKR2012007964-appb-I000064
    (식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
    R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
    R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
    R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
    [화학식 2][Formula 2]
    Figure PCTKR2012007964-appb-I000065
    Figure PCTKR2012007964-appb-I000065
    (식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
    R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
    R10는 (a)
    Figure PCTKR2012007964-appb-I000066
    또는 (b)
    Figure PCTKR2012007964-appb-I000067
    이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),
    R 10 is (a)
    Figure PCTKR2012007964-appb-I000066
    Or (b)
    Figure PCTKR2012007964-appb-I000067
    E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
    [화학식 3][Formula 3]
    Figure PCTKR2012007964-appb-I000068
    Figure PCTKR2012007964-appb-I000068
    (식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
    R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
    [화학식 4][Formula 4]
    Figure PCTKR2012007964-appb-I000069
    Figure PCTKR2012007964-appb-I000069
    (식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
    R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  4. 청구항 3에 있어서, 상기 접착력 강화제는 상기 화학식 2 내지 화학식 4로 표시되는 화합물 중 어느 하나와 상기 화학식 1로 표시되는 화합물의 혼합물인 배향막 형성용 조성물.The composition of claim 3, wherein the adhesion enhancer is a mixture of any one of the compounds represented by Formulas 2 to 4 and the compound represented by Formula 1. 4.
  5. 청구항 1에 있어서, 신나메이트기를 포함하는 고분자를 광배향제로 포함하는 배향막 형성용 조성물.The composition for forming an alignment film according to claim 1, comprising a polymer containing a cinnamate group as a photoalignment agent.
  6. 청구항 5에 있어서, 상기 광배향제 100 중량부에 대하여 0.1 중량부 내지 20 중량부의 접착력 강화제를 포함하는 배향막 형성용 조성물.The composition for forming an alignment layer of claim 5, further comprising 0.1 part by weight to 20 parts by weight of an adhesion enhancing agent with respect to 100 parts by weight of the photoalignment agent.
  7. 청구항 1에 있어서, 트리아진계 화합물, 아세토페논계 화합물, 비이미다졸계 화합물, 옥심계 화합물, 벤조인계 화합물, 벤조페논계 화합물, 티오크산톤계 화합물 및 안트라센계 화합물로 이루어진 군에서 선택되는 1종 이상의 광개시제를 포함하는 배향막 형성용 조성물.The compound according to claim 1, which is selected from the group consisting of a triazine compound, an acetophenone compound, a biimidazole compound, an oxime compound, a benzoin compound, a benzophenone compound, a thioxanthone compound and an anthracene compound The composition for forming an alignment film containing the above photoinitiator.
  8. 청구항 1에 있어서, 에틸렌글리콜모노메틸에테르, 에틸렌글리콜모노에틸에테르, 에틸렌글리콜모노프로필에테르, 에틸렌글리콜모노부틸에테르, 디에틸렌글리콜디메틸에테르, 디에틸렌글리콜디에틸에테르, 디에틸렌글리콜에틸메틸에테르, 디에틸렌글리콜디프로필에테르, 디에틸렌글리콜디부틸에테르, 메틸셀로솔브아세테이트, 에틸셀로솔브아세테이트, 에틸렌글리콜모노부틸에테르아세테이트, 에틸렌글리콜모노에틸에테르아세테이트, 프로필렌글리콜모노메틸에테르아세테이트, 프로필렌글리콜모노에틸에테르아세테이트, 프로필렌글리콜모노프로필에테르아세테이트, 메톡시부틸아세테이트, 메톡시펜틸아세테이트, 프로필렌글리콜모노메틸에테르, 프로필렌글리콜모노에틸에테르, 프로필렌글리콜모노프로필에테르, 프로필렌글리콜모노부틸에테르, 프로필렌글리콜디메틸에테르, 프로필렌글리콜디에틸에테르, 프로필렌글리콜에틸메틸에테르, 프로필렌글리콜디프로필에테르프로필렌글리콜프로필메틸에테르, 프로필렌글리콜에틸프로필에테르, 프로필렌글리콜메틸에테르프로피오네이트, 프로필렌글리콜에틸에테르프로피오네이트, 프로필렌글리콜프로필에테르프로피오네이트, 프로필렌글리콜부틸에테르프로피오네이트, 메톡시부틸알코올, 에톡시부틸알코올, 프로폭시부틸알코올, 부톡시부틸알코올, 메톡시부틸아세테이트, 에톡시부틸아세테이트, 프로폭시부틸아세테이트, 부톡시부틸아세테이트, 메톡시부틸프로피오네이트, 에톡시부틸프로피오네이트, 프로폭시부틸프로피오네이트, 부톡시부틸프로피오네이트, 디프로필렌글리콜디메틸에테르, 디프로필렌글리콜디에틸에테르, 디프로필렌글리콜메틸에틸에테르, 벤젠, 톨루엔, 자일렌, 메시틸렌, 메틸에틸케톤, 아세톤, 메틸아밀케톤, 메틸이소부틸케톤, 시클로헥사논, 에탄올, 프로판올, 부탄올, 헥산올, 시클로헥산올, 에틸렌글리콜, 글리세린, 아세트산메틸, 아세트산에틸, 아세트산프로필, 아세트산부틸, 2-히드록시프로피온산에틸, 2-히드록시-2-메틸프로피온산메틸, 2-히드록시-2-메틸프로피온산에틸, 히드록시아세트산메틸, 히드록시아세트산에틸, 히드록시아세트산부틸, 락트산메틸, 락트산에틸, 락트산프로필, 락트산부틸, 3-히드록시프로피온산메틸, 3-히드록시프로피온산에틸, 3-히드록시프로피온산프로필, 3-히드록시프로피온산부틸, 2-히드록시-3-메틸부탄산메틸, 메톡시아세트산메틸, 메톡시아세트산에틸, 메톡시아세트산프로필, 메톡시아세트산부틸, 에톡시아세트산메틸, 에톡시아세트산에틸, 에톡시아세트산프로필, 에톡시아세트산부틸, 프로폭시아세트산메틸, 프로폭시아세트산에틸, 프로폭시아세트산프로필, 프로폭시아세트산부틸, 부톡시아세트산메틸, 부톡시아세트산에틸, 부톡시아세트산프로필, 부톡시아세트산부틸, 2-메톡시프로피온산메틸, 2-메톡시프로피온산에틸, 2-메톡시프로피온산프로필, 2-메톡시프로피온산부틸, 2-에톡시프로피온산메틸, 2-에톡시프로피온산에틸, 2-에톡시프로피온산프로필, 2-에톡시프로피온산부틸, 2-부톡시프로피온산메틸, 2-부톡시프로피온산에틸, 2-부톡시프로피온산프로필, 2-부톡시프로피온산부틸, 3-메톡시프로피온산메틸, 3-메톡시프로피온산에틸, 3-메톡시프로피온산프로필, 3-메톡시프로피온산부틸, 3-에톡시프로피온산메틸, 3-에톡시프로피온산에틸, 3-에톡시프로피온산프로필, 3-에톡시프로피온산부틸, 3-프로폭시프로피온산메틸, 3-프로폭시프로피온산에틸, 3-프로폭시프로피온산프로필, 3-프로폭시프로피온산부틸, 3-부톡시프로피온산메틸, 3-부톡시프로피온산에틸, 3-부톡시프로피온산프로필, 3-부톡시프로피온산부틸, 테트라히드로푸란, 피란 및 γ-부티로락톤으로 이루어진 군에서 선택되는 1종 이상의 유기용매를 포함하는 배향막 형성용 조성물.The method of claim 1, wherein ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, ethylene glycol monobutyl ether, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol ethyl methyl ether, di Ethylene glycol dipropyl ether, diethylene glycol dibutyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, ethylene glycol monobutyl ether acetate, ethylene glycol monoethyl ether acetate, propylene glycol monomethyl ether acetate, propylene glycol monoethyl Ether acetate, propylene glycol monopropyl ether acetate, methoxybutyl acetate, methoxypentyl acetate, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monopropyl ether, propylene glycol monobutyl Ether, propylene glycol dimethyl ether, propylene glycol diethyl ether, propylene glycol ethyl methyl ether, propylene glycol dipropyl ether propylene glycol propyl methyl ether, propylene glycol ethyl propyl ether, propylene glycol methyl ether propionate, propylene glycol ethyl ether propio Nitrate, propylene glycol propyl ether propionate, propylene glycol butyl ether propionate, methoxy butyl alcohol, ethoxy butyl alcohol, propoxy butyl alcohol, butoxy butyl alcohol, methoxy butyl acetate, ethoxy butyl acetate, propoxy Butyl acetate, butoxybutyl acetate, methoxybutyl propionate, ethoxybutyl propionate, propoxybutyl propionate, butoxybutyl propionate, dipropylene glycol dimethyl ether, dipropylene glycol diethyl ether, diph in Pylene glycol methyl ethyl ether, benzene, toluene, xylene, mesitylene, methyl ethyl ketone, acetone, methyl amyl ketone, methyl isobutyl ketone, cyclohexanone, ethanol, propanol, butanol, hexanol, cyclohexanol, ethylene glycol , Glycerin, methyl acetate, ethyl acetate, propyl acetate, butyl acetate, ethyl 2-hydroxypropionate, methyl 2-hydroxy-2-methylpropionate, ethyl 2-hydroxy-2-methylpropionate, methyl hydroxyacetate, hydroxy Ethyl hydroxy acetate, butyl hydroxy acetate, methyl lactate, ethyl lactate, propyl lactate, butyl lactate, methyl 3-hydroxypropionate, ethyl 3-hydroxypropionate, 3-hydroxypropionate, butyl 3-hydroxypropionate, 2 Hydroxy-3-methylbutyrate, methyl methoxyacetate, ethyl methoxyacetate, methoxyacetate, methoxy butyl acetate, methyl ethoxyacetate, Ethyl oxyacetate, ethoxy acetate propyl, butyl ethoxy acetate, methyl propoxy acetate, ethyl propoxy acetate, propyl propoxy acetate, butyl propoxy acetate, methyl butoxy acetate, butoxy acetate, butoxy acetate propyl Butyl oxyacetate, 2-methoxy methyl propionate, 2-methoxy ethylpropionate, 2-methoxy propyl propionate, 2-methoxy butyl propionate, 2-ethoxy propionate, 2-ethyl ethoxypropionate, 2-ethoxy Propyl propionate, butyl 2-ethoxypropionate, methyl 2-butoxypropionate, ethyl 2-butoxypropionate, propyl 2-butoxypropionate, butyl 2-butoxypropionate, methyl 3-methoxypropionate, 3-methoxypropionic acid Ethyl, 3-methoxypropionate, butyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, propyl 3-ethoxypropionate, 3 Butyl ethoxypropionate, methyl 3-propoxypropionate, ethyl 3-propoxypropionate, propyl 3-propoxypropionate, butyl 3-propoxypropionate, methyl 3-butoxypropionate, ethyl 3-butoxypropionate, 3- A composition for forming an alignment film comprising at least one organic solvent selected from the group consisting of propyl butoxypropionate, butyl 3-butoxypropionate, tetrahydrofuran, pyran and γ-butyrolactone.
  9. 청구항 1 내지 8 중 어느 한 항의 배향막 형성용 조성물로 형성된 배향막.An alignment film formed of the composition for forming an alignment film of any one of claims 1 to 8.
  10. 기재, 상기 기재 상에 형성된 청구항 9의 배향막, 및 상기 배향막 상에 형성된 액정층을 포함하는 위상차 필름.A retardation film comprising a substrate, an alignment film of claim 9 formed on the substrate, and a liquid crystal layer formed on the alignment film.
  11. 청구항 10에 있어서, 상기 기재는 그 표면에 상기 배향막 형성용 조성물의 접착력 강화제에 포함된 이소시아네이트기 및 (메타)아크릴레이트기와 결합될 수 있는 반응성기를 포함하는 위상차 필름.The retardation film of claim 10, wherein the substrate includes an isocyanate group and a reactive group which may be bonded to a (meth) acrylate group included in an adhesion enhancing agent of the composition for forming an alignment layer on a surface thereof.
  12. 청구항 11에 있어서, 상기 기재 표면의 반응성기는 수산기, 티올기, 카르복시기, (메타)아크릴레이트기, 아민기 또는 에폭시기인 위상차 필름.The retardation film according to claim 11, wherein the reactive group on the surface of the substrate is a hydroxyl group, a thiol group, a carboxyl group, a (meth) acrylate group, an amine group or an epoxy group.
  13. 청구항 11에 있어서, 상기 배향막은 상기 기재와 우레탄 결합, 티올렌 결합 또는 탄소-탄소 포화결합에 의해 접합된 위상차 필름.The retardation film of claim 11, wherein the alignment layer is bonded to the substrate by a urethane bond, a thiylene bond, or a carbon-carbon saturated bond.
  14. 청구항 11에 있어서, 상기 기재는 표면처리된 트리아세틸셀룰로오스계, 사이클로올레핀계 또는 PMMA계 중합체를 포함하는 위상차 필름.The retardation film of claim 11, wherein the substrate comprises a triacetylcellulose-based, cycloolefin-based, or PMMA-based polymer.
  15. 청구항 14에 있어서, 상기 표면처리는 검화 처리, 프라이머 처리, 코로나 처리, 플라즈마 처리 및 코팅 처리로 이루어진 군에서 선택되는 적어도 하나의 처리인 위상차 필름.The retardation film of claim 14, wherein the surface treatment is at least one treatment selected from the group consisting of saponification treatment, primer treatment, corona treatment, plasma treatment, and coating treatment.
  16. 청구항 15에 있어서, 상기 플라즈마 처리는 원격 플라즈마(Remote plasma) 처리, 직접 플라즈마(Direct plasma) 처리 및 단량체 플라즈마(Monomer plasma) 처리로 이루어진 군에서 선택되는 적어도 하나인 위상차 필름.The retardation film of claim 15, wherein the plasma treatment is at least one selected from the group consisting of a remote plasma treatment, a direct plasma treatment, and a monomer plasma treatment.
  17. 청구항 13에 있어서, 상기 우레탄 결합은 상기 배향막의 하기 화학식 1 내지 4 중 어느 하나로 표시되는 화합물의 이소시아네이트기와 상기 기재의 수산기, 티올기, 카르복시기, 아민기 또는 에폭시기의 반응에 의해 형성되는 것인 위상차 필름:The retardation film according to claim 13, wherein the urethane bond is formed by a reaction of an isocyanate group of a compound represented by any one of the following Chemical Formulas 1 to 4 of the alignment layer with a hydroxyl group, a thiol group, a carboxyl group, an amine group, or an epoxy group of the substrate. :
    [화학식 1][Formula 1]
    Figure PCTKR2012007964-appb-I000070
    Figure PCTKR2012007964-appb-I000070
    (식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
    R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
    R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
    R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
    [화학식 2][Formula 2]
    Figure PCTKR2012007964-appb-I000071
    Figure PCTKR2012007964-appb-I000071
    (식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
    R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
    R10는 (a)
    Figure PCTKR2012007964-appb-I000072
    또는 (b)
    Figure PCTKR2012007964-appb-I000073
    이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),
    R 10 is (a)
    Figure PCTKR2012007964-appb-I000072
    Or (b)
    Figure PCTKR2012007964-appb-I000073
    E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
    [화학식 3][Formula 3]
    Figure PCTKR2012007964-appb-I000074
    Figure PCTKR2012007964-appb-I000074
    (식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
    R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
    [화학식 4][Formula 4]
    Figure PCTKR2012007964-appb-I000075
    Figure PCTKR2012007964-appb-I000075
    (식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
    R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  18. 청구항 13에 있어서, 상기 탄소-탄소 포화 결합은 상기 배향막의 하기 화학식 1 내지 4 중 어느 하나로 표시되는 화합물의 (메타)아크릴레이트기와 상기 기재의 (메타)아크릴레이트기의 반응에 의해 형성되는 것인 위상차 필름:The method according to claim 13, wherein the carbon-carbon saturated bond is formed by the reaction of the (meth) acrylate of the compound represented by any one of the following formulas 1 to 4 of the alignment layer with the (meth) acrylate group of the substrate Retardation film:
    [화학식 1][Formula 1]
    Figure PCTKR2012007964-appb-I000076
    Figure PCTKR2012007964-appb-I000076
    (식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
    R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
    R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
    R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
    [화학식 2][Formula 2]
    Figure PCTKR2012007964-appb-I000077
    Figure PCTKR2012007964-appb-I000077
    (식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
    R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
    R10는 (a)
    Figure PCTKR2012007964-appb-I000078
    또는 (b)
    Figure PCTKR2012007964-appb-I000079
    이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),
    R 10 is (a)
    Figure PCTKR2012007964-appb-I000078
    Or (b)
    Figure PCTKR2012007964-appb-I000079
    E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
    [화학식 3][Formula 3]
    Figure PCTKR2012007964-appb-I000080
    Figure PCTKR2012007964-appb-I000080
    (식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
    R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
    [화학식 4][Formula 4]
    Figure PCTKR2012007964-appb-I000081
    Figure PCTKR2012007964-appb-I000081
    (식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
    R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  19. 청구항 13에 있어서, 상기 티올렌 결합은 상기 배향막의 하기 화학식 1 내지 4 중 어느 하나로 표시되는 화합물의 (메타)아크릴레이트기와 상기 기재의 티올기의 반응에 의해 형성되는 것인 위상차 필름:The phase difference film of claim 13, wherein the thiylene bond is formed by a reaction of a (meth) acrylate group of a compound represented by any one of the following Chemical Formulas 1 to 4 of the alignment layer with a thiol group of the substrate:
    [화학식 1][Formula 1]
    Figure PCTKR2012007964-appb-I000082
    Figure PCTKR2012007964-appb-I000082
    (식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
    R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
    R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
    R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
    [화학식 2][Formula 2]
    Figure PCTKR2012007964-appb-I000083
    Figure PCTKR2012007964-appb-I000083
    (식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
    R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
    R10는 (a)
    Figure PCTKR2012007964-appb-I000084
    또는 (b)
    Figure PCTKR2012007964-appb-I000085
    이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),
    R 10 is (a)
    Figure PCTKR2012007964-appb-I000084
    Or (b)
    Figure PCTKR2012007964-appb-I000085
    E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
    [화학식 3][Formula 3]
    Figure PCTKR2012007964-appb-I000086
    Figure PCTKR2012007964-appb-I000086
    (식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
    R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
    [화학식 4][Formula 4]
    Figure PCTKR2012007964-appb-I000087
    Figure PCTKR2012007964-appb-I000087
    (식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
    R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  20. 청구항 10에 있어서, 상기 배향막은 상기 액정층과 우레탄 결합 또는 탄소-탄소 포화 결합으로 접합된 위상차 필름.The retardation film of claim 10, wherein the alignment layer is bonded to the liquid crystal layer by a urethane bond or a carbon-carbon saturated bond.
  21. 청구항 10에 있어서, 상기 액정층은 탄소-탄소 불포화 결합, 수산기, 에폭시기 또는 시아노기를 갖는 액정성 화합물로 형성된 것인 위상차 필름.The retardation film of claim 10, wherein the liquid crystal layer is formed of a liquid crystal compound having a carbon-carbon unsaturated bond, a hydroxyl group, an epoxy group, or a cyano group.
  22. 청구항 20에 있어서, 상기 우레탄 결합은 상기 배향막의 하기 화학식 1 내지 4 중 어느 하나로 표시되는 화합물의 이소시아네이트기와 상기 액정층의 액정성 화합물의 수산기, 에폭시기 또는 시아노기의 반응에 의해 형성되는 것인 위상차 필름:The retardation film of claim 20, wherein the urethane bond is formed by a reaction of an isocyanate group of a compound represented by any one of the following Formulas 1 to 4 of the alignment layer with a hydroxyl group, an epoxy group, or a cyano group of the liquid crystal compound of the liquid crystal layer. :
    [화학식 1][Formula 1]
    Figure PCTKR2012007964-appb-I000088
    Figure PCTKR2012007964-appb-I000088
    (식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
    R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
    R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
    R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
    [화학식 2][Formula 2]
    Figure PCTKR2012007964-appb-I000089
    Figure PCTKR2012007964-appb-I000089
    (식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
    R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
    R10는 (a)
    Figure PCTKR2012007964-appb-I000090
    또는 (b)
    Figure PCTKR2012007964-appb-I000091
    이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),
    R 10 is (a)
    Figure PCTKR2012007964-appb-I000090
    Or (b)
    Figure PCTKR2012007964-appb-I000091
    E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
    [화학식 3][Formula 3]
    Figure PCTKR2012007964-appb-I000092
    Figure PCTKR2012007964-appb-I000092
    (식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
    R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
    [화학식 4][Formula 4]
    Figure PCTKR2012007964-appb-I000093
    Figure PCTKR2012007964-appb-I000093
    (식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
    R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  23. 청구항 20에 있어서, 상기 탄소-탄소 포화 결합은 상기 배향막의 하기 화학식 1 내지 4 중 어느 하나로 표시되는 화합물의 (메타)아크릴레이트기와 상기 액정층의 액정성 화합물의 탄소-탄소 불포화 결합의 반응에 의해 형성되는 것인 위상차 필름:The method of claim 20, wherein the carbon-carbon saturation bond is a reaction of a (meth) acrylate group of the compound represented by any one of the following formulas 1 to 4 of the alignment layer and the carbon-carbon unsaturated bond of the liquid crystal compound of the liquid crystal layer Retardation film to be formed:
    [화학식 1][Formula 1]
    Figure PCTKR2012007964-appb-I000094
    Figure PCTKR2012007964-appb-I000094
    (식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
    R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
    R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
    R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
    [화학식 2][Formula 2]
    Figure PCTKR2012007964-appb-I000095
    Figure PCTKR2012007964-appb-I000095
    (식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
    R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
    R10는 (a)
    Figure PCTKR2012007964-appb-I000096
    또는 (b)
    Figure PCTKR2012007964-appb-I000097
    이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),
    R 10 is (a)
    Figure PCTKR2012007964-appb-I000096
    Or (b)
    Figure PCTKR2012007964-appb-I000097
    E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
    [화학식 3][Formula 3]
    Figure PCTKR2012007964-appb-I000098
    Figure PCTKR2012007964-appb-I000098
    (식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
    R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
    [화학식 4][Formula 4]
    Figure PCTKR2012007964-appb-I000099
    Figure PCTKR2012007964-appb-I000099
    (식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
    R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  24. 청구항 10 내지 23 중 어느 한 항에 있어서, 상기 액정층은 이소시아네이트기 및 (메타)아크릴레이트기를 그 말단에 포함하는 접착력 강화제를 더 포함하여 형성된 것인 위상차 필름.The retardation film according to any one of claims 10 to 23, wherein the liquid crystal layer further includes an adhesion enhancing agent including an isocyanate group and a (meth) acrylate group at its terminals.
  25. 청구항 24에 있어서, 상기 액정층과 상기 배향막은 서로 모두 포함하고 있는 상기 접착력 강화제 간의 탄소-탄소 포화결합을 포함하는 화학적 결합으로 접합된 위상차 필름.The retardation film of claim 24, wherein the liquid crystal layer and the alignment layer are bonded by a chemical bond including a carbon-carbon saturation bond between the adhesion promoters, which are both included in each other.
  26. 청구항 24에 있어서, 상기 접착력 강화제는 하기 화학식 1 내지 4의 화합물로 이루어진 군에서 선택된 1종 이상의 것인 위상차 필름:The retardation film of claim 24, wherein the adhesion promoter is one or more selected from the group consisting of compounds of Formulas 1 to 4:
    [화학식 1][Formula 1]
    Figure PCTKR2012007964-appb-I000100
    Figure PCTKR2012007964-appb-I000100
    (식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
    R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
    R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
    R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
    [화학식 2][Formula 2]
    Figure PCTKR2012007964-appb-I000101
    Figure PCTKR2012007964-appb-I000101
    (식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
    R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
    R10는 (a)
    Figure PCTKR2012007964-appb-I000102
    또는 (b)
    Figure PCTKR2012007964-appb-I000103
    이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),
    R 10 is (a)
    Figure PCTKR2012007964-appb-I000102
    Or (b)
    Figure PCTKR2012007964-appb-I000103
    E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
    [화학식 3][Formula 3]
    Figure PCTKR2012007964-appb-I000104
    Figure PCTKR2012007964-appb-I000104
    (식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
    R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
    [화학식 4][Formula 4]
    Figure PCTKR2012007964-appb-I000105
    Figure PCTKR2012007964-appb-I000105
    (식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
    R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  27. 청구항 24에 있어서, 상기 액정층은 상기 액정성 화합물 100 중량부에 대하여 상기 접착력 강화제 0.1 내지 15 중량부를 포함하는 위상차 필름.The retardation film according to claim 24, wherein the liquid crystal layer comprises 0.1 to 15 parts by weight of the adhesion enhancing agent with respect to 100 parts by weight of the liquid crystal compound.
PCT/KR2012/007964 2011-10-07 2012-09-28 Composition for forming an alignment layer, and alignment layer and phase difference film manufactured using same WO2013051831A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201280049523.4A CN103857751A (en) 2011-10-07 2012-09-28 Composition for forming an alignment layer, and alignment layer and phase difference film manufactured using same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2011-0102640 2011-10-07
KR1020110102640A KR20130038020A (en) 2011-10-07 2011-10-07 Composition for preparing photoalignment layer and photoalignment layer prepared from the same
KR10-2011-0138604 2011-12-20
KR1020110138604 2011-12-20

Publications (2)

Publication Number Publication Date
WO2013051831A2 true WO2013051831A2 (en) 2013-04-11
WO2013051831A3 WO2013051831A3 (en) 2013-05-30

Family

ID=48044287

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/007964 WO2013051831A2 (en) 2011-10-07 2012-09-28 Composition for forming an alignment layer, and alignment layer and phase difference film manufactured using same

Country Status (2)

Country Link
CN (1) CN103857751A (en)
WO (1) WO2013051831A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013147607A (en) * 2012-01-23 2013-08-01 Sumitomo Chemical Co Ltd Composition and optical film
WO2015016330A1 (en) * 2013-08-02 2015-02-05 ダイキン工業株式会社 Novel compound having unsaturated group and composition including said compound
CN104629774A (en) * 2013-11-11 2015-05-20 Jsr株式会社 Liquid crystal orientation agent, liquid crystal orientation film and production method thereof, and liquid crystal display element and production method thereof
US10066108B2 (en) 2013-08-02 2018-09-04 Daikin Industries, Ltd. Composition including fluorine-containing polymer comprising at least one type of group selected from group comprising polymerizable functional groups and cross-linkable functional groups; and coated article

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10613258B2 (en) * 2016-09-13 2020-04-07 Ubright Optronics Corporation Optical assembly and the method to make the same
KR102126051B1 (en) * 2017-10-23 2020-06-23 삼성에스디아이 주식회사 Liquid crystal retardation film, polarizing plate for light emitting display apparatus comprising the same and light emitting display apparatus compsiring the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0841433A (en) * 1994-07-29 1996-02-13 Nippon Synthetic Chem Ind Co Ltd:The Adhesive composition
KR20030081459A (en) * 2001-02-23 2003-10-17 니폰 가야꾸 가부시끼가이샤 A phase difference film comprising polymer film having ultraviolet curable resin composition for alignment film and liquid crystalline compound
KR20090013408A (en) * 2007-08-01 2009-02-05 주식회사 엘지화학 Composition for liquid crystal alignment film
KR20100112525A (en) * 2009-04-09 2010-10-19 주식회사 엘지화학 Polymerizable alignment composition, alignment layer prepared thereof, a method for preparing alignment layer, optical film and display apparatus comprising the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2209320C (en) * 1997-06-30 2006-07-18 Kansai Paint Co., Ltd. Process for production of powder coating
KR101362591B1 (en) * 2006-03-17 2014-02-21 키모토 컴파니 리미티드 Binder composition for polyester film and optical film using same
JP2008137948A (en) * 2006-12-01 2008-06-19 Showa Denko Kk Polymerizable monomer composition and polymerization-inhibiting method
US8747605B2 (en) * 2008-08-11 2014-06-10 Dow Global Technologies Llc One-part structural epoxy resin adhesives containing elastomeric tougheners capped with phenols and hydroxy-terminated acrylates or hydroxy-terminated methacrylates

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0841433A (en) * 1994-07-29 1996-02-13 Nippon Synthetic Chem Ind Co Ltd:The Adhesive composition
KR20030081459A (en) * 2001-02-23 2003-10-17 니폰 가야꾸 가부시끼가이샤 A phase difference film comprising polymer film having ultraviolet curable resin composition for alignment film and liquid crystalline compound
KR20090013408A (en) * 2007-08-01 2009-02-05 주식회사 엘지화학 Composition for liquid crystal alignment film
KR20100112525A (en) * 2009-04-09 2010-10-19 주식회사 엘지화학 Polymerizable alignment composition, alignment layer prepared thereof, a method for preparing alignment layer, optical film and display apparatus comprising the same

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013147607A (en) * 2012-01-23 2013-08-01 Sumitomo Chemical Co Ltd Composition and optical film
WO2015016330A1 (en) * 2013-08-02 2015-02-05 ダイキン工業株式会社 Novel compound having unsaturated group and composition including said compound
JP5673885B1 (en) * 2013-08-02 2015-02-18 ダイキン工業株式会社 NOVEL COMPOUND HAVING UNSATURATED GROUP AND COMPOSITION CONTAINING THE COMPOUND
US10066108B2 (en) 2013-08-02 2018-09-04 Daikin Industries, Ltd. Composition including fluorine-containing polymer comprising at least one type of group selected from group comprising polymerizable functional groups and cross-linkable functional groups; and coated article
CN104629774A (en) * 2013-11-11 2015-05-20 Jsr株式会社 Liquid crystal orientation agent, liquid crystal orientation film and production method thereof, and liquid crystal display element and production method thereof

Also Published As

Publication number Publication date
CN103857751A (en) 2014-06-11
WO2013051831A3 (en) 2013-05-30

Similar Documents

Publication Publication Date Title
WO2013051831A2 (en) Composition for forming an alignment layer, and alignment layer and phase difference film manufactured using same
WO2015108386A1 (en) Novel β-oximester fluorene compound, a photopolymerization initiator comprising same, and photoresist composition
WO2015016456A1 (en) Retardation film and image display device having same
WO2015008925A1 (en) Polarising film and image display apparatus having same
WO2013094969A2 (en) Polarizing plate and image display device having same
WO2017010768A1 (en) Cross-linkable composition
WO2019013516A1 (en) Circular polarizer
WO2014193072A1 (en) Optical film with excellent ultraviolet cut-off function and polarizing plate including same
WO2017119764A1 (en) Film touch sensor and manufacturing method therefor
WO2015046713A1 (en) Polarizing plate
WO2020111522A1 (en) Photosensitive resin composition, film, and electronic device
WO2016085087A9 (en) (meth)acrylic compounds having high refractive index, preparation method therefor, optical sheet comprising same, and optical display device comprising same
WO2012177043A2 (en) Optical film
WO2023167562A1 (en) Optical film, composition for forming coating layer, and electronic device
WO2021132865A1 (en) Polymer resin compound, method for producing same, and photosensitive resin composition comprising same
WO2022045737A1 (en) Positive photosensitive resin composition
WO2020105810A1 (en) Cellulose ester phase difference film
WO2020080625A1 (en) Coating-type polarizing film using diacetylene-based lyotropic liquid crystal mixture containing iodines, and manufacturing method therefor
WO2020105933A1 (en) Liquid crystal alignment agent composition, method for preparing liquid crystal alignment film by using same, and liquid crystal alignment film and liquid crystal display device which use same
WO2014065517A1 (en) Hardening resin composition and optical film manufactured by using same
WO2022182014A1 (en) Photonic crystal structure and manufacturing method therefor
WO2017171272A1 (en) Color filter and image display device comprising same
WO2017171271A1 (en) Film touch sensor and touch screen panel comprising same
WO2014204142A1 (en) Radical-curable adhesive composition and polarizing plate comprising same
WO2021261848A1 (en) Multi-structured film having improved interference fringe, and display device comprising same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12838945

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12838945

Country of ref document: EP

Kind code of ref document: A2